<SEC-DOCUMENT>0001213900-26-067658.txt : 20260611
<SEC-HEADER>0001213900-26-067658.hdr.sgml : 20260611
<ACCEPTANCE-DATETIME>20260611113015
ACCESSION NUMBER:		0001213900-26-067658
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260610
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260611
DATE AS OF CHANGE:		20260611

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Triller Group Inc.
		CENTRAL INDEX KEY:			0001769624
		STANDARD INDUSTRIAL CLASSIFICATION:	INVESTMENT ADVICE [6282]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38909
		FILM NUMBER:		261081900

	BUSINESS ADDRESS:	
		STREET 1:		7119 WEST SUNSET BOULEVARD
		STREET 2:		SUITE 782
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90046
		BUSINESS PHONE:		310-893-5090

	MAIL ADDRESS:	
		STREET 1:		7119 WEST SUNSET BOULEVARD
		STREET 2:		SUITE 782
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90046

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AGBA Group Holding Ltd.
		DATE OF NAME CHANGE:	20221115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AGBA Acquisition Ltd
		DATE OF NAME CHANGE:	20190304
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0294347-8k_triller.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:us-roles="http://fasb.org/us-roles/2026" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:country="http://xbrl.sec.gov/country/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:ILLR="http://agba.com/20260610">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02F_US%2DGAAP%2D2026 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_ILLR_agba.com_20260610 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20260610_20260610 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0001769624 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000004" name="dei:EntityCentralIndexKey">0001769624</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="illr-20260610.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-06-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001769624</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-06-10</xbrli:startDate>
        <xbrli:endDate>2026-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-06-102026-06-10_custom_CommonStock0.001ParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001769624</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ILLR:CommonStock0.001ParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-06-10</xbrli:startDate>
        <xbrli:endDate>2026-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-06-102026-06-10_custom_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001769624</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ILLR:WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-06-10</xbrli:startDate>
        <xbrli:endDate>2026-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="text-transform: uppercase"><b>United
States</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Form&#160;<span id="xdx_904_edei--DocumentType_c20260610__20260610_zFAr3LrxOZBe"><ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Current Report</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section 13 or 15(d) of
the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_902_edei--DocumentPeriodEndDate_c20260610__20260610_zXBM7e5cnXXl"><ix:nonNumeric contextRef="AsOf2026-06-10" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 10, 2026</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event
reported)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_908_edei--EntityRegistrantName_c20260610__20260610_zTVbkv7K58z3"><ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000011" name="dei:EntityRegistrantName">TRILLER GROUP INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact Name of Registrant as Specified
in its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center; font-size: 10pt"><span style="font-size: 10pt"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20260610__20260610_zAMFn9CoBHTb"><ix:nonNumeric contextRef="AsOf2026-06-10" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center; font-size: 10pt"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--EntityFileNumber_c20260610__20260610_zKCNxKMduuY8"><ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000013" name="dei:EntityFileNumber">001-38909</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center; font-size: 10pt"><span style="font-size: 10pt"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20260610__20260610_zs9cDeaSbuIk"><ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000014" name="dei:EntityTaxIdentificationNumber">33-1473901</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt">(State or other jurisdiction<br/>
of incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt">(I.R.S. Employer<br/>
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center; font-size: 10pt"><span style="font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20260610__20260610_z61ywFGmcmHk"><ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000015" name="dei:EntityAddressAddressLine1">1301 N Broadway, STE 98065</ix:nonNumeric></span>,<br/>
<span id="xdx_90D_edei--EntityAddressCityOrTown_c20260610__20260610_z1TRRwMUKtrf"><ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000016" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span>,&#160;<span id="xdx_909_edei--EntityAddressStateOrProvince_c20260610__20260610_zZB1L8EZPEOj"><ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000017" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center; font-size: 10pt"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressPostalZipCode_c20260610__20260610_zPzLs8lrwOif"><ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000018" name="dei:EntityAddressPostalZipCode">90012</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt">(Address of Principal Executive Offices)</span></td>
    <td>&#160;</td>
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&#8217;s telephone number,
including area code:&#160;<b>(<span id="xdx_909_edei--CityAreaCode_c20260610__20260610_zSkTWCf6x8xd"><ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000019" name="dei:CityAreaCode">947</ix:nonNumeric></span>)&#160;<span id="xdx_904_edei--LocalPhoneNumber_c20260610__20260610_zZRy8GBbbxqe"><ix:nonNumeric contextRef="AsOf2026-06-10" id="Fact000020" name="dei:LocalPhoneNumber">622-9043</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former address, if changed
since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--WrittenCommunications_c20260610__20260610_zBHF93slIVp5"><ix:nonNumeric contextRef="AsOf2026-06-10" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--SolicitingMaterial_c20260610__20260610_zbz58aa9FuM2"><ix:nonNumeric contextRef="AsOf2026-06-10" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20260610__20260610_zlGZmdFShiR6"><ix:nonNumeric contextRef="AsOf2026-06-10" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20260610__20260610_z7Zfg4hzPlAb"><ix:nonNumeric contextRef="AsOf2026-06-10" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center; font-size: 10pt"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center; font-size: 10pt"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center; font-size: 10pt"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt"><span id="xdx_901_edei--Security12bTitle_c20260610__20260610__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.001ParValueMember_zFRGM90220w"><ix:nonNumeric contextRef="From2026-06-102026-06-10_custom_CommonStock0.001ParValueMember" id="Fact000025" name="dei:Security12bTitle">Common Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20260610__20260610__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.001ParValueMember_zickf1bs8PBc"><ix:nonNumeric contextRef="From2026-06-102026-06-10_custom_CommonStock0.001ParValueMember" id="Fact000026" name="dei:TradingSymbol">ILLR</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt"><span id="xdx_90E_edei--SecurityExchangeName_c20260610__20260610__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.001ParValueMember_zhkr6ENd06Xe"><ix:nonNumeric contextRef="From2026-06-102026-06-10_custom_CommonStock0.001ParValueMember" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>&#160;Capital Market</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt"><span id="xdx_905_edei--Security12bTitle_c20260610__20260610__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember_zaWp3xLdWqge"><ix:nonNumeric contextRef="From2026-06-102026-06-10_custom_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" id="Fact000028" name="dei:Security12bTitle">Warrants, each warrant exercisable for one-quarter of one share of Common Stock for $23.00 per full share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20260610__20260610__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember_z1KgxBoJP7qd"><ix:nonNumeric contextRef="From2026-06-102026-06-10_custom_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" id="Fact000029" name="dei:TradingSymbol">ILLRW</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 10pt"><span id="xdx_901_edei--SecurityExchangeName_c20260610__20260610__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember_zxfJwGfPHt0c"><ix:nonNumeric contextRef="From2026-06-102026-06-10_custom_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" format="ixt-sec:exchnameen" id="Fact000030" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>&#160;Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of
the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Emerging growth company&#160;<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--EntityEmergingGrowthCompany_c20260610__20260610_zBXtqlzfRsNe"><ix:nonNumeric contextRef="AsOf2026-06-10" format="ixt:booleanfalse" id="Fact000031" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>Item&#160;5.07.</b>&#160;<b>Submission of Matters to
a Vote of Security Holders.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">On June 10, 2026, Triller Group Inc.
(the &#8220;Company&#8221;) held its 2025 annual meeting of shareholders (the &#8220;Annual Meeting&#8221;) at 20F Foyer, 625 King&#8217;s
Road, North Point, Hong Kong. As of May 13, 2025, the record date set by the Company&#8217;s Board of Directors, there were 198,854,372
shares of Common Stock, par value $0.001 per share (the &#8220;Common Stock&#8221;) and 11,801,804 shares of Series A-1 Preferred Stock
issued and entitled to be voted at the Special Meeting, of which 114,094,392 or approximately 54.16% of the total outstanding shares of
Common Stock and Series A-1 Preferred Stock, were represented in person or by proxy; therefore, a quorum was present. The following proposals
were presented at the Annual Meeting:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><b>1. Election of Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">All of the following four nominees
were elected to the Company&#8217;s Board of Directors, in accordance with the voting results listed below, to serve until the next Annual
Meeting and until their successors have been duly elected and have qualified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 25%"><span style="font-size: 10pt"><b>Nominee</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>For</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Broker Non-Vote</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Ng Wing Fai</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">111,355,798</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2,738,594</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Brian Chan</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">111,621,665</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2,472,727</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Thomas Ng</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">111,583,754</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2,510,638</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Felix Yun Pun Wong </span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">111,619,688</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2,474,704</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>2. Ratification of the Company&#8217;s Independent Auditors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">Shareholders ratified the appointment
of Enrome LLP as the independent auditors of the Company for the fiscal year ended December 31, 2025, in accordance with the voting results
listed below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 25%; text-align: center"><span style="font-size: 10pt"><b>For</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Abstain</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Broker Non-Vote</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">112,764,808</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">195,155</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1,134,429</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><b>3. Approval of an amendment to the
Company&#8217;s Certificate of Incorporation (the &#8220;Certificate of Incorporation&#8221;) to effect a reverse stock split of our common
stock, par value $0.001 per share (the &#8220;Common Stock&#8221;) by a ratio of no more than 1-for-10 at any time within one year after
the 2025 Annual Meeting, with the exact ratio to be determined within this range as determined by the Board in its sole discretion.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">Shareholders approved an amendment
to the Company&#8217;s Certificate of Incorporation (the &#8220;Certificate of Incorporation&#8221;) to effect a reverse stock split of
our common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;) by a ratio of no more than 1-for-10 at any time within one
year after the 2025 Annual Meeting, with the exact ratio to be determined within this range as determined by the Board in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 25%; text-align: center"><span style="font-size: 10pt"><b>For</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Abstain</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Broker Non-Vote</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">106,765,882</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6,200,982 </span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1,127,528 </span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b></b></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><b>4. Approval of an amendment to the
Company&#8217;s Certificate of Incorporation to change the name of the Company from &#8220;Triller Group Inc.&#8221; to &#8220;Eight Holdings
Inc.&#8221;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">Shareholders approved an amendment
to the Company&#8217;s Certificate of Incorporation to change the name of the Company from &#8220;Triller Group Inc.&#8221; to &#8220;Eight
Holdings Inc.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 25%; text-align: center"><span style="font-size: 10pt"><b>For</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Abstain</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Broker Non-Vote</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">112,530,474</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">368,602</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1,195,316</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><b>5. Approval of the Triller Group
Inc. 2026 Equity Incentive Plan (the &#8220;2026 Equity Incentive Plan&#8221;), including the reservation of 39,600,000 shares of Common
Stock for issuance thereunder.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">Shareholders approved the Triller Group
Inc. 2026 Equity Incentive Plan, including the reservation of 39,600,000 shares of Common Stock for issuance thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 25%; text-align: center"><span style="font-size: 10pt"><b>For</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Abstain</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Broker Non-Vote</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">104,726,262</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">7,920,615</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1,447,515</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><b>6. Approval of, in accordance with
Nasdaq Listing Rule 5635(d), the issuance of shares of common stock (or securities convertible into or exercisable for common stock) in
one or more private placements in excess of 20% of our outstanding common stock.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">Shareholders approved, in accordance
with Nasdaq Listing Rule 5635(d), the issuance of shares of common stock (or securities convertible into or exercisable for common stock)
in one or more private placements including a potential private investment in public equity (&#8220;PIPE&#8221;) financing of up to $300
million. The offering will consist of between 200 million to 300 million shares of common stock at a price of between US$1.00 per share
to US$1.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 25%; text-align: center"><span style="font-size: 10pt"><b>For</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Against</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Abstain</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-size: 10pt"><b>Broker Non-Vote</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-size: 10pt">107,210,774</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">5,412,726</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1,470,892</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">0</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify"><b>Item&#160;9.01. Financial Statements
and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: top; width: 9%; text-align: justify"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="white-space: nowrap; vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; width: 90%; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.1</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea029434701ex10-1.htm">Triller Group Inc. 2026 Equity Incentive Plan</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="text-transform: uppercase"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the requirements
of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3"><span style="font-size: 10pt"><b>TRILLER GROUP INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><b>By:</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>/s/ Shu Pei Huang, Desmond</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">Name:&#160;</span></td>
    <td style="width: 32%"><span style="font-size: 10pt">Shu Pei Huang, Desmond</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td><span style="font-size: 10pt">Acting Chief Financial Officer</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Dated: June 11, 2026</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1j89uwjAMxp+Ad7AqjgzSsnHobasKmgajAsR2DcUdFW3cOSl/HmlvuTQFwWGLIsWOv88/2/N63oTGeYEMny+LKaywrAppEBaYIaNK0Sqi17cQ7LvAr1wblsq49GqMyHrQekb9J2n/nfKQa9yGIEYDXwyCEfh++DiEZOZ1mnpEKsu3qEwuC5BqCwlTxTkayee2w0qeSFF5dqQ1ss5JheD3RVv+gUD4AbzTQR6J9xqm08jr9NzpeBOmurKq+GRQNU6ICywtTrfu23XTpLU2VIYfkpvddCzT3SWOT8hpruWmwDHxXOF3LdkgzzMbL3eScZ7Z9UtSS0Pp3mqCYV+IBHlcF4UTzLDcIFuKL4LAF8+XBa6wHqDFwbFNAW9AyIiBFD5cmEBZk4JuujZJCwZHduKug0NltZnFt8o/Fr2bWFiDn0hey6L+b9R7Tg+6zgKVZDg0pmv/X/5Rtf0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea029434701ex10-1.htm
<DESCRIPTION>TRILLER GROUP INC. 2026 EQUITY INCENTIVE PLAN
<TEXT>
<HTML>
<BODY>

		<p class="ParaOverride-2" style="border-width: 0; padding: 0; margin-top: 0; margin-bottom: 0; margin-left: 18pt; margin-top: 0pt; orphans: 2; text-align: right; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Exhibit
  10.1</b></font></p>

<p class="ParaOverride-2" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 18pt; orphans: 2; text-align: center; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>

<p class="ParaOverride-2" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 18pt; orphans: 2; text-align: center; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>TRILLER&nbsp;GROUP&nbsp;INC.</b></font></p>

<p class="ParaOverride-2" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 18pt; orphans: 2; text-align: center; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
		<p class="ParaOverride-2" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 18pt; margin-top: 0pt; orphans: 2; text-align: center; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>2026
  EQUITY INCENTIVE PLAN</b></font></p>

<p class="ParaOverride-2" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 18pt; orphans: 2; text-align: center; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>1.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>PURPOSE
                                            OF THE PLAN; DEFINITIONS</b></font></td>
</tr></table>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
name of the plan is the&nbsp;Triller&nbsp;Group&nbsp;Inc.&nbsp;2026 Equity Incentive Plan (the &ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Plan</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;).
The purpose of the Plan is to encourage and enable the Employees, Non-Employee Directors and Consultants of&nbsp;Triller&nbsp;Group&nbsp;Inc.&nbsp;(the
&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Company</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;)
and its Affiliates upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business
to acquire a proprietary interest in the Company. It is anticipated that providing such persons with a direct stake in the Company&rsquo;s
welfare will assure a closer identification of their interests with those of the Company and its stockholders, thereby stimulating their
efforts on the Company&rsquo;s behalf and strengthening their desire to remain with the Company.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
  following terms shall be defined as set forth below unless the context otherwise requires:</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Act</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrator</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means either the Board or the compensation committee of the Board or a similar committee performing the functions of the compensation
  committee and which, if necessary to comply with Rule 16b-3 or relevant securities exchange or inter-dealer quotation service, is comprised
  solely of two or more Non-Employee Directors who are &ldquo;independent&rdquo; for purposes of any applicable listing requirements.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Affiliate</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means, at the time of determination, any &ldquo;parent&rdquo; or &ldquo;subsidiary&rdquo; of the Company as such terms are defined in Rule 405 of the Act.
  The Board will have the authority to determine the time or times at which &ldquo;parent&rdquo; or &ldquo;subsidiary&rdquo; status is determined within the
  foregoing definition.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Award</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means, individually or collectively (except where referring to a particular category of grant under the Plan), any Incentive Stock
  Option, Non-Qualified Stock Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit Award, Unrestricted Stock
  Award, or Dividend Equivalent Right.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Award
  Agreement</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means a written agreement, contract, certificate or other instrument or document evidencing the terms and conditions of an individual
  Award granted under the Plan, which may, in the discretion of the Company, be transmitted electronically to any Grantee under the Plan.
  Each Award Agreement is subject to the terms and conditions of the Plan.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Board</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means the Board of Directors of the Company.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cause</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means, unless the applicable Award Agreement provides otherwise:</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-top: 0pt; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">With
                                            respect to any Employee or Consultant, (i)&nbsp;if the Grantee is a party to an employment
                                            or service agreement with the Company or an Affiliate that provides a definition of Cause
                                            (or a similar term), the definition contained therein, or (ii) for a Grantee who is not a
                                            party to such an agreement, &ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cause</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
                                            means the Grantee&rsquo;s (1) intentional failure to perform reasonably assigned duties, (2) dishonesty
                                            or willful misconduct in the performance of the Grantee&rsquo;s duties, (3) involvement in a transaction
                                            that is materially adverse to the Company or an Affiliate, (4) breach of fiduciary duty involving
                                            personal profit, (5) willful violation of any law, rule, regulation or court order (other
                                            than misdemeanor traffic violations and misdemeanors not involving misuse or misappropriation
                                            of money or property), (6) commission of an act of fraud or intentional misappropriation
                                            or conversion of any asset or opportunity of the Company or an Affiliate, or (7) material
                                            breach of any provision of the Plan or the Grantee&rsquo;s Award Agreement or any other written
                                            agreement between the Grantee and the Company or an Affiliate, in each case as determined
                                            in good faith by the Board, the determination of which shall be final, conclusive and binding
                                            on all parties.</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>




<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">With
                                            respect to any Non-Employee Director, a determination by a majority of the disinterested
                                            Board members that the Grantee has engaged in (i) malfeasance in office, (ii) gross misconduct
                                            or neglect,&nbsp;(iii) false&nbsp;or fraudulent misrepresentation inducing the Non-Employee
                                            Director&rsquo;s appointment,&nbsp;(iv) willful&nbsp;conversion of corporate funds, or (v) repeated
                                            failure to participate in Board meetings on a regular basis despite having received proper
                                            notice of meetings in advance.</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
  Administrator, in its absolute discretion, shall determine the effect of all matters and questions relating to whether a Grantee&rsquo;s
  Service Relationship has been terminated for Cause.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
  in Control</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means, except as otherwise provided in an Award Agreement or in an employment or consulting agreement with the Company or an Affiliate
  that has been approved by the Administrator, the occurrence of any one or more of the following events or conditions:</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Any
                                            person (as such term is used in Sections 13(d) and 14(d)(2) of the Exchange Act, hereinafter
                                            in this definition, &ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Person</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;),
                                            other than the Company or an Affiliate or an Employee benefit plan of the Company or an Affiliate,
                                            becomes the beneficial owner (as defined in Rule 13d-3 under the Exchange Act), directly
                                            or indirectly, of securities of the Company representing more than 50% of the combined voting
                                            power of the Company&rsquo;s then outstanding securities;</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
                                            closing of a merger, consolidation or other business combination (a &ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
                                            Combination</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;)
                                            other than a Business Combination in which holders of the Stock immediately prior to the
                                            Business Combination have substantially the same proportionate ownership of the common stock
                                            or ordinary shares, as applicable, of the surviving corporation immediately after the Business
                                            Combination as immediately before;</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(c)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
                                            closing of an agreement for the sale or disposition of all or substantially all of the Company&rsquo;s
                                            assets to any Person that is not an Affiliate;</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(d)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
                                            approval by the Company&rsquo;s stockholders of a plan of complete liquidation of the Company,
                                            other than a merger of the Company into any Subsidiary or a liquidation as a result of which
                                            Persons who were stockholders of the Company immediately prior to such liquidation have substantially
                                            the same proportionate ownership of shares of common stock or ordinary shares, as applicable,
                                            of the surviving corporation immediately after such liquidation as immediately before; or</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(e)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Within
                                            any 24-month period, the Incumbent Directors cease to constitute at least a majority of the
                                            Board or the board of directors of any successor to the Company;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">,&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>however</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">,
                                            that any director elected to the Board, or nominated for election, by a majority of the Incumbent
                                            Directors then still in office, shall be deemed to be an Incumbent Director for purposes
                                            of this paragraph 1(e), but excluding, for this purpose, any such individual whose initial
                                            assumption of office occurs as a result of either an actual or threatened election contest
                                            with respect to the election or removal of directors or other actual or threatened solicitation
                                            of proxies or consents by or on behalf of an individual, entity or &ldquo;group&rdquo; other than the
                                            Board (including, but not limited to, any such assumption that results from any other paragraph
                                            of this definition).</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Notwithstanding
  the foregoing, solely for the purpose of determining the timing of any payments pursuant to any Award constituting &ldquo;deferred compensation&rdquo;
  that is subject to Code Section&nbsp;409A, a Change in Control shall be limited to a &ldquo;change in the ownership of the Company,&rdquo; a &ldquo;change
  in the effective control of the Company,&rdquo; or a &ldquo;change in the ownership of a substantial portion of the assets of the Company&rdquo; as such
  terms are defined in Section&nbsp;1.409A-3(i)(5) of the U.S. Treasury Regulations.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Code</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means the Internal Revenue Code of 1986, as amended, and any successor thereto. Reference to the any section of the Code is deemed
  to include any regulations or other interpretive guidance under such section, and any amendments or successor provisions to such section,
  regulations or guidance.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consultant</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means an individual who provides&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>bona
  fide</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;services
  to the Company or an Affiliate as an independent contractor and who qualifies as a consultant or advisor under Instruction A.1.(a)(1)
  of Form S-8 under the Act.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0pt; margin-bottom: 0pt; orphans: 2; text-align: justify; widows: 2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0pt; margin-bottom: 0pt; orphans: 2; text-align: justify; widows: 2"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-4" style="border-width: 0; padding: 0pt; margin-bottom: 0pt; orphans: 2; text-align: justify; widows: 2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>


	<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividend
 Equivalent Right</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
 means an Award entitling the Grantee to receive credits based on cash dividends that would have been paid on the shares of Stock specified
 in the Dividend Equivalent Right (or other award to which it relates) if such shares had been issued to and held by the Grantee.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Effective
  Date</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means ______.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employee</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means any individual, including an officer or director, employed by the Company or an Affiliate;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;that
  for purposes of determining eligibility to receive Incentive Stock Options, an Employee means an employee of the Company or a parent
  or subsidiary corporation within the meaning of Section 424 of the Code. Mere service as a director or payment of a director&rsquo;s fee
  by the Company or an Affiliate is not sufficient to constitute &ldquo;employment&rdquo; by the Company or an Affiliate.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exchange
  Act</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
  Market Value</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means, as of any given date, the fair market value of a share of Stock as determined as follows: if the Stock is listed on the Nasdaq
  Stock Market, The New York Stock Exchange or any other established stock exchange or a national market system, the Fair Market Value
  shall be the closing price of a share of Stock (or if no sales were reported the closing price on the date immediately preceding such
  date) as quoted on such exchange or system on the day of determination, as reported in the&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>Wall
  Street Journal</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;or
  other reliable source. In the absence of an established market for the Stock, the Fair Market Value shall be determined in good faith
  by the Administrator and such determination shall be conclusive and binding on all persons.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Grantee</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means an Employee, Non-Employee Director or Consultant who has been granted an Award, or any such individual&rsquo;s beneficiary, estate
  or representative who has acquired such Award in accordance with the terms of the Plan.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Incentive
  Stock Option</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means any Stock Option designated and qualified as an &ldquo;incentive stock option&rdquo; as defined in Section 422 of the Code.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Incumbent
  Director</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means, with respect to any period of time specified under the Plan for purposes of determining whether or not a Change in Control has
  occurred, the individuals who were members of the Board at the beginning of such period.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-Employee
  Director</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means a member of the Board who is a &ldquo;non-employee director&rdquo; as defined in Rule 16b-3.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-Qualified
  Stock Option</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means any Stock Option that is not an Incentive Stock Option.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Option</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  or &ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock Option</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means any option to purchase shares of Stock granted pursuant to Section 5.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
  Shares</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means the shares of Stock underlying a Restricted Stock Award that remain subject to a risk of forfeiture or the Company&rsquo;s right of
  repurchase.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
  Stock Award</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means an Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time of grant.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
  Stock Units</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means an Award of stock units subject to such restrictions and conditions as the Administrator may determine at the time of grant.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rule
  16b-3</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</FONT></P>

<P CLASS="ParaOverride-4" STYLE="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><FONT CLASS="CharOverride-3" STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sale
  Price</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means the value as determined by the Administrator of the consideration payable, or otherwise to be received by stockholders, per share
  of Stock pursuant to a Change in Control.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Section
  409A</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means Section 409A of the Code and the regulations and other guidance promulgated thereunder.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<P CLASS="ParaOverride-4" STYLE="border-width: 0; padding: 0; margin-top: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Service
Relationship</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&rdquo;
means any relationship as an Employee, director or Consultant of the Company or any Affiliate (e.g., a Service Relationship shall be
deemed to continue without interruption in the event an individual&rsquo;s status changes from full-time Employee to part-time Employee or
Consultant). If a Grantee&rsquo;s Service Relationship is with an Affiliate that ceases to be an Affiliate, the Grantee&rsquo;s Service Relationship
shall be deemed terminated for purposes </font><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">of
the Plan. For purposes of the Plan, a Service Relationship shall not be deemed terminated merely as a result of (i) a transfer of employment
to the Company from an Affiliate or from the Company to an Affiliate, or from one Affiliate to another; or (ii) an approved leave of
absence for military service or sickness, or for any other purpose approved by the Company, if the Employee&rsquo;s right to re-employment
is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator
otherwise so provides in writing.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means the common stock of the Company, par value $0.0001 per share, subject to adjustments pursuant to Section 3.</FONT></P>

<P CLASS="ParaOverride-4" STYLE="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><FONT CLASS="CharOverride-3" STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
  Appreciation Right</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means an Award entitling the recipient to receive shares of Stock (or cash, to the extent explicitly provided for in the applicable
  Award Agreement) having a value equal to the excess of the Fair Market Value of the Stock on the date of exercise over the exercise
  price of the Stock Appreciation Right multiplied by the number of shares of Stock with respect to which the Stock Appreciation Right
  shall have been exercised.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Subsidiary</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means any corporation or other entity (other than the Company) in which the Company has at least a 50% interest, either directly or
  indirectly.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ten
  Percent Owner</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means an Employee who owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than 10% of
  the combined voting power of all classes of stock of the Company or any parent corporation or subsidiary corporation (as both terms
  are defined in Code Section 424).</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Total
  and Permanent Disability</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means the inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment
  that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12 months,
  within the meaning of Section 22(e)(3) of the Code.</FONT></P>

<P CLASS="ParaOverride-4" STYLE="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><FONT CLASS="CharOverride-3" STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Unrestricted
  Stock Award</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;
  means an Award of shares of Stock free of any restrictions.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>2.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>ADMINISTRATION</b></font></td>
</tr></table>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Administration
                                            of Plan</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Plan shall be administered by the Administrator.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Authority
                                            of Administrator</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Subject to the other provisions of the Plan, the Administrator&rsquo;s charter and applicable laws,
                                            and in addition to other express powers and authorization conferred by the Plan, the Administrator
                                            shall have the sole power and authority, in its discretion, to make all determinations under
                                            the Plan, including the power and authority:</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(i)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">from
                                            time to time to select, subject to the limitations in the Plan, the eligible individuals
                                            to whom Awards may be granted;</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(ii)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            determine when Awards are to be granted under the Plan and the applicable Grant Date;</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(iii)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            determine the number of shares of Stock to be subject to any Award;</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(iv)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            determine whether each Option is to be an Incentive Stock Option or a Non-Qualified Stock
                                            Option;</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(v)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            prescribe the terms and conditions of each Award, including, without limitation, the exercise
                                            price and medium of payment and vesting provisions, and to specify the provisions of the
                                            Award Agreement relating to such grant;</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(vi)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            construe and interpret the Plan and apply its provisions;</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(vii)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            amend any outstanding Award, including for the purpose of modifying the time or manner of
                                            vesting, or the term of any outstanding Award;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided,
                                            however</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">,
                                            that if any such amendment impairs a Grantee&rsquo;s rights or increases a Grantee&rsquo;s obligations
                                            under his or her Award or creates or increases a Grantee&rsquo;s federal income tax liability with
                                            respect to an Award, such amendment shall also be subject to the Grantee&rsquo;s consent;</font></td>
</tr></table>





	<p class="ParaOverride-6" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(viii)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            determine the duration and purpose of leaves of absences that may be granted to a Grantee
                                            without constituting termination of their Service Relationship for purposes of the Plan,
                                            which periods shall be no shorter than the periods generally applicable to Employees under
                                            the Company&rsquo;s employment policies;</font></td>
</tr></table>
		<p class="ParaOverride-6" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">(ix)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">to
                                            adopt, amend and rescind rules, regulations and guidelines relating to the administration
                                            of the Plan;</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(x)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            make decisions with respect to outstanding Awards that may become necessary upon a Change
                                            in Control or an event that triggers anti-dilution adjustments;</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(xi)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            interpret, administer, reconcile any inconsistency in, correct any defect in or supply any
                                            omission in the Plan and any instrument or agreement relating to, or Award granted under,
                                            the Plan;</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(xii)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            decide all disputes arising in connection with the Plan; and</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.35in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(xiii)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">to
                                            exercise discretion to make any and all other determinations which it determines to be necessary
                                            or advisable for the administration of the Plan.</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(c)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Administrator
                                            Decisions Final</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            All decisions made by the Administrator pursuant to the Plan shall be final and binding on
                                            the Company and the Grantees, unless such decisions are determined by a court having jurisdiction
                                            to be arbitrary and capricious.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(d)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Administrator
                                            Action</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Subject to compliance with all applicable laws, action by the Administrator shall require
                                            the consent of a majority of the members of the Administrator, expressed either orally at
                                            a meeting of the Administrator or in writing in the absence of a meeting. No member of the
                                            Administrator shall have any liability for any good faith action, inaction or determination
                                            in connection with the Plan.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(e)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Delegation
                                            of Authority to Grant Awards</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Subject to applicable law, the Administrator, in its discretion, may delegate to a committee
                                            consisting of one or more officers of the Company (such committee, the &ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Officer
                                            Committee</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;),
                                            all or part of the Administrator&rsquo;s authority and duties with respect to the granting of Awards
                                            (the &ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Delegated
                                            Awards</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;)
                                            to individuals who are not subject to the reporting and other provisions of Section 16 of
                                            the Exchange Act and not members of the Officer Committee. Any such delegation by the Administrator
                                            shall include a limitation as to the amount of Stock underlying Awards that may be granted
                                            during the period of the delegation and shall contain guidelines as to the determination
                                            of the exercise price and the vesting criteria. The Administrator may revoke or amend the
                                            terms of a delegation at any time but such action shall not invalidate any prior actions
                                            of the Administrator&rsquo;s delegate or delegates that were consistent with the terms of the Plan.
                                            Additionally, in order to evidence the Officer Committee&rsquo;s approval of Delegated Award grants
                                            pursuant to any delegation of authority, the Company shall compile a record documenting the
                                            Officer Committee&rsquo;s approval of Delegated Award grants. Such record will list the name of
                                            each Grantee, the type and amount of Delegated Awards approved for grant, the grant date,
                                            the vesting schedule for the Delegated Awards and any other non-standard material terms.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(f)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Award
                                            Agreement</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Awards under the Plan shall be evidenced by Award Agreements that set forth the terms, conditions
                                            and limitations for each Award which may include, without limitation, the term of an Award
                                            and the provisions applicable in the event employment or service terminates.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(g)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Indemnification</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Neither the Board nor the Administrator, nor any member of either or any delegate thereof,
                                            shall be liable for any act, omission, interpretation, construction or determination made
                                            in good faith in connection with the Plan, and the members of the Board and the Administrator
                                            (and any delegate thereof) shall be entitled in all cases to indemnification and reimbursement
                                            by the Company in respect of any claim, loss, damage or expense (including, without limitation,
                                            reasonable attorneys&rsquo; fees) arising or resulting therefrom to the fullest extent permitted
                                            by law and/or under the Company&rsquo;s articles or bylaws or any directors&rsquo; and officers&rsquo; liability
                                            insurance coverage which may be in effect from time to time&nbsp;and/or&nbsp;any indemnification
                                            agreement between such individual and the Company.</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>




	<p class="ParaOverride-5" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-top: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(h)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Foreign
                                            Award Recipients</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws
                                            in other countries in which the Company and its Subsidiaries operate or have Employees or
                                            other individuals eligible for Awards, the Administrator, in its sole discretion, shall have
                                            the power and authority to: (i) determine which Subsidiaries shall be covered by the Plan;
                                            (ii) determine which individuals outside the United States are eligible to participate in
                                            the Plan; (iii) modify the terms and conditions of any Award granted to individuals outside
                                            the United States to comply with applicable foreign laws; (iv) establish sub-plans and modify
                                            exercise procedures and other terms and procedures, to the extent the Administrator determines
                                            such actions to be necessary or advisable (and such sub-plans and/or modifications shall
                                            be attached to this Plan as appendices);&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">,&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>however</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">,
                                            that no such sub-plans and/or modifications shall increase the share limitations contained
                                            in Section 3(a) hereof; and&nbsp;(v) take&nbsp;any action, before or after an Award is made,
                                            that the Administrator determines to be necessary or advisable to obtain approval or comply
                                            with any local governmental regulatory exemptions or approvals. Notwithstanding the foregoing,
                                            the Administrator may not take any actions hereunder, and no Awards shall be granted, that
                                            would violate the Exchange Act or any other applicable United States securities law, the
                                            Code, or any other applicable United States governing statute or law.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>3.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>STOCK
                                            ISSUABLE UNDER THE PLAN; MERGERS; SUBSTITUTION</b></font></td>
</tr></table>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Authorized
                                            Shares</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Subject to any adjustments as necessary pursuant to Section 3(b), the aggregate number of
                                            shares of Stock reserved and available for grant and issuance under the Plan is&nbsp;30,400,000.
                                            If (i) any Option or other Award granted hereunder is exercised through the tendering of
                                            Stock (either actually or by attestation) or by the withholding of Stock by the Company,
                                            or (ii) tax or deduction liabilities arising from such Option or other Award are satisfied
                                            by the tendering of Stock (either actually or by attestation) or by the withholding of Stock
                                            by the Company, then in each such case the shares of Stock so tendered or withheld shall
                                            not be added back to the shares of Stock available for grant under the Plan. Only shares
                                            of Stock underlying Awards under this Plan that are forfeited, canceled, or expire unexercised,
                                            shall be available again for issuance under the Plan. The shares of Stock to be issued pursuant
                                            to the grant or exercise of an Award may consist of authorized but unissued shares, shares
                                            purchased on the open market or shares previously issued and outstanding and reacquired by
                                            the Company. Subject to Section 3(b), the aggregate maximum number of shares of Stock that
                                            may be issued pursuant to the exercise of Incentive Stock Options is 14,089,571 shares.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Changes
                                            in Stock</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Subject to Section 3(c), if, as a result of any reorganization, recapitalization, reclassification,
                                            stock dividend, cash dividend, stock split, reverse stock split or other similar change in
                                            the Company&rsquo;s capital stock, the outstanding shares of Stock are increased or decreased or
                                            are exchanged for a different number or kind of shares or other securities of the Company,
                                            or additional shares or new or different shares or other securities of the Company or other
                                            non-cash assets are distributed with respect to such shares of Stock or other securities,
                                            or, if, as a result of any merger or consolidation, sale of all or substantially all of the
                                            assets of the Company, the outstanding shares of Stock are converted into or exchanged for
                                            securities of the Company or any successor entity (or a parent or subsidiary thereof), the
                                            Administrator shall make an appropriate or proportionate adjustment in (i) the maximum number
                                            of shares reserved for issuance under the Plan, including the maximum number of shares that
                                            may be issued in the form of Incentive Stock Options, (ii) the number and kind of shares
                                            or other securities subject to any then outstanding Awards under the Plan, (iii) the repurchase
                                            price, if any, per share subject to each outstanding Restricted Stock Award, and (iv) the
                                            exercise price for each share subject to any then outstanding Stock Options and Stock Appreciation
                                            Rights under the Plan, without changing the aggregate exercise price (i.e., the exercise
                                            price multiplied by the number of shares subject to Stock Options and Stock Appreciation
                                            Rights) as to which such Stock Options and Stock Appreciation Rights remain exercisable.
                                            The Administrator shall also make equitable or proportionate adjustments in the number of
                                            shares subject to outstanding Awards and the exercise price and the terms of outstanding
                                            Awards to take into consideration cash dividends paid other than in the ordinary course or
                                            any other extraordinary corporate event. Unless the Administrator specifically determines
                                            that such adjustment is in the best interests of the Company or its Affiliates, the Administrator
                                            shall, in the case of Incentive Stock Options, ensure that any adjustments under this Section
                                            3(b) will not constitute a modification, <font style="font-variant: normal">extension or
                                            renewal of the Incentive Stock Options within the meaning of Section 424(h)(3) of the Code
                                            and in the case of Non-qualified Stock Options and Stock Appreciation Rights, ensure that
                                            any adjustments under this Section 3(b) will not constitute a modification of such Awards
                                            within the meaning of Section 409A of the Code. Any adjustments made under this Section 3(b)
                                            shall be made in a manner that does not adversely affect the exemption provided pursuant
                                            to Rule 16b-3. The adjustment by the Administrator shall be final, binding and conclusive.
                                            No fractional shares of Stock shall be issued under the Plan resulting from any such adjustment,
                                            but the Administrator in its discretion may make a cash payment in lieu of fractional shares.</font></font></td>
</tr></table>


<p class="ParaOverride-7" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>

<p class="ParaOverride-7" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-7" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(c)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Change
                                            in Control</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            In the case of and subject to the consummation of a Change in Control, the parties thereto
                                            may cause the assumption or continuation of Awards theretofore granted by the successor entity,
                                            or the substitution of such Awards with new Awards of the successor entity or parent thereof,
                                            with appropriate adjustment as to the number and kind of shares and, if appropriate, the
                                            per share exercise prices, as such parties shall agree. To the extent the parties to such
                                            Change in Control do not provide for the assumption, continuation or substitution of Awards,
                                            upon the effective time of the Change in Control, the Plan and all outstanding Awards granted
                                            hereunder shall terminate. In such case, the Administrator may, in its sole discretion, at
                                            the time an Award is granted or at any time before, coincident with or following the effective
                                            time of the Change in Control, cause any Award with time-based vesting, conditions or restrictions
                                            to become partially or fully vested and exercisable or non-forfeitable as of the effective
                                            time of the Change in Control or any other time or date fixed by the Administrator; and/or
                                            cause any Award with conditions and restrictions relating to the attainment of performance
                                            goals to become vested and exercisable or non-forfeitable in connection with the Change in
                                            Control in the Administrator&rsquo;s discretion or to the extent specified in the relevant Award
                                            Agreement. In the event of such termination, (i) the Company shall have the option (in its
                                            sole discretion) to make or provide for a payment, in cash or in kind, to any Grantee holding
                                            an Option or Stock Appreciation Right, in exchange for the cancellation thereof, in an amount
                                            equal to the difference between (A) the Sale Price multiplied by the number of shares of
                                            Stock subject to the Option or Stock Appreciation Right (to the extent then exercisable at
                                            prices not in excess of the Sale Price) and (B) the exercise price of the Option or Stock
                                            Appreciation Right;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided
                                            that</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">,
                                            in the case of an Option or Stock Appreciation Right with an exercise price equal to or greater
                                            than the Sale Price, such Option or Stock Appreciation Right shall be cancelled for no consideration;
                                            or (ii) each Grantee shall be permitted, within a specified period of time prior to the consummation
                                            of the Change in Control as determined by the Administrator, to exercise all outstanding
                                            Options and Stock Appreciation Rights (to the extent then exercisable) held by such Grantee.
                                            The Company shall also have the option (in its sole discretion) to make or provide for a
                                            payment, in cash or in kind, to the Grantees holding other Awards in an amount equal to the
                                            Sale Price multiplied by the number of vested shares of Stock under such Awards.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(d)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>No
                                            Adjustment for Certain Awards</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Except as hereinabove expressly provided, the issuance by the Company of shares of any class
                                            or securities convertible into shares of any class, for cash, property, labor or services,
                                            upon direct sale, upon the exercise of rights or warrants to subscribe therefor or upon conversion
                                            of shares or obligations of the Company convertible into such shares or other securities,
                                            and in any case whether or not for fair value, shall not affect previously granted Awards,
                                            and no adjustment by reason thereof shall be made with respect to the number of shares of
                                            Stock subject to Awards theretofore granted or the purchase price per share of Stock, if
                                            applicable.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(e)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Powers
                                            not Affected</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The existence of the Plan and the Awards granted hereunder shall not affect in any way the
                                            right or power of the Board or of the stockholders of the Company to make or authorize any
                                            adjustment, recapitalization, reorganization or other change of the Company&rsquo;s capital structure
                                            or business, any merger or consolidation of the Company, any issue of debt or equity securities
                                            ahead of or affecting the Stock or the rights thereof, the dissolution or liquidation of
                                            the Company or any sale, lease, exchange or other disposition of all or any part of its assets
                                            or business or any other corporate act or proceeding.</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

	<p class="ParaOverride-3" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-top: 0; margin-bottom: 0; margin-left: 36pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>4.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>ELIGIBILITY</b></font></td>
</tr></table>
		<p class="ParaOverride-8" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p class="ParaOverride-8" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">Awards
may be granted under the Plan to such Employees, Non-Employee Directors or Consultants of the Company and its Affiliates as are selected
from time to time by the Administrator in its sole discretion;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;that
Non-Qualified Stock Options may be granted only to Employees, Non-Employee Directors or Consultants who are providing services to the
Company or a Subsidiary, and Incentive Stock Options may be granted only to Employees of the Company or of a parent corporation or subsidiary
corporation within the meaning of Section 424(f) of the Code.</font></p>

<p class="ParaOverride-8" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>5.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>STOCK
                                            OPTIONS</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Award
                                            of Stock Options</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Administrator may grant Stock Options under the Plan. Any Stock Option granted under
                                            the Plan shall be in such form as the Administrator may from time to time approve. A Stock
                                            Option may be either an Incentive Stock Option or a Non-Qualified Stock Option. Incentive
                                            Stock Options may be granted only to Employees of the Company or any Affiliate that is a
                                            &ldquo;parent corporation&rdquo; or &ldquo;subsidiary corporation&rdquo; within the meaning of Section 424(f) of
                                            the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it
                                            shall be deemed a Non-Qualified Stock Option. Stock Options granted pursuant to this Section
                                            5 shall be subject to the following terms and conditions and shall contain such additional
                                            terms and conditions, not inconsistent with the Plan, as the Administrator deems desirable.
                                            If the Administrator so determines, Stock Options may be granted in lieu of cash compensation
                                            at the optionee&rsquo;s election, subject to such terms and conditions as the Administrator may
                                            establish.</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Exercise
                                            Price</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The exercise price per share for the Stock covered by a Stock Option granted pursuant to
                                            this Section 5 shall be determined by the Administrator at the time of grant but shall not
                                            be less than 100% of the Fair Market Value on the date of grant. In the case of an Incentive
                                            Stock Option that is granted to a Ten Percent Owner, the exercise price of such Incentive
                                            Stock Option shall be not less than 110% of the Fair Market Value on the grant date. Notwithstanding
                                            the foregoing, Stock Options may be granted with an exercise price per share that is less
                                            than 100% of the Fair Market Value on the date of grant (i) pursuant to a transaction described
                                            in, and in a manner consistent with, Section 424(a) of the Code, (ii) to individuals who
                                            are not subject to U.S. income tax on the date of grant or (iii) if the Stock Option is otherwise
                                            compliant with Section 409A.</font></td>
</tr></table>
		<p class="ParaOverride-5" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(c)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Option
                                            Term</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The term of each Stock Option shall be fixed by the Administrator, but no Stock Option shall
                                            be exercisable more than ten years after the date the Stock Option is granted. In the case
                                            of an Incentive Stock Option that is granted to a Ten Percent Owner, the term of such Stock
                                            Option shall be no more than five years from the date of grant.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(d)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Exercisability;
                                            Rights of a Stockholder</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Stock Options shall become exercisable at such time or times, whether or not in installments,
                                            as shall be determined by the Administrator at or after the grant date. The Administrator
                                            may at any time accelerate the exercisability of all or any portion of any Stock Option.
                                            An optionee shall have the rights of a stockholder only as to shares acquired upon the exercise
                                            of a Stock Option and not as to unexercised Stock Options.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(e)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Method
                                            of Exercise</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Stock Options may be exercised in whole or in part, by giving written or electronic notice
                                            of exercise to the Company, specifying the number of shares to be purchased. Payment of the
                                            purchase price may be made by one or more of the following methods except to the extent otherwise
                                            provided in the Award Agreement:</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(i)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">In
                                            cash, by certified or bank check or other instrument acceptable to the Administrator;</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(ii)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Through
                                            the delivery (or attestation to the ownership following such procedures as the Company may
                                            prescribe) of shares of Stock that are not then subject to restrictions under any Company
                                            plan. Such surrendered shares shall be valued at Fair Market Value on the exercise date;</font></td>
</tr></table>


	<p class="ParaOverride-6" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(iii)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">By
                                            the optionee delivering to the Company a properly executed exercise notice together with
                                            irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable
                                            and acceptable to the Company for the purchase price;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;that
                                            in the event the optionee chooses to pay the purchase price as so provided, the optionee
                                            and the broker shall comply with such procedures and enter into such agreements of indemnity
                                            and other agreements as the Company shall prescribe as a condition of such payment procedure;
                                            or</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(iv)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">With
                                            respect to Stock Options that are not Incentive Stock Options, by a &ldquo;net exercise&rdquo; arrangement
                                            pursuant to which the Company will reduce the number of shares of Stock issuable upon exercise
                                            by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate
                                            exercise price.</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Payment
  instruments will be received subject to collection. The transfer to the optionee on the records of the Company or of the transfer agent
  of the shares of Stock to be purchased pursuant to the exercise of a Stock Option will be contingent upon receipt from the optionee
  (or a purchaser acting in his stead in accordance with the provisions of the Stock Option) by the Company of the full purchase price
  for such shares and the fulfillment of any other requirements contained in the Award Agreement or applicable provisions of laws (including
  the satisfaction of any withholding taxes that the Company is obligated to withhold with respect to the optionee). In the event an
  optionee chooses to pay the purchase price by previously-owned shares of Stock through the attestation method, the number of shares
  of Stock transferred to the optionee upon the exercise of the Stock Option shall be net of the number of attested shares. In the event
  that the Company establishes, for itself or using the services of a third party, an automated system for the exercise of Stock Options,
  such as a system using an internet website or interactive voice response, then the paperless exercise of Stock Options may be permitted
  through the use of such an automated system.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(f)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Annual
                                            Limit on Incentive Stock Options</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            To the extent required for &ldquo;incentive stock option&rdquo; treatment under Section 422 of the Code,
                                            the aggregate Fair Market Value (determined as of the time of grant) of the shares of Stock
                                            with respect to which Incentive Stock Options granted under this Plan and any other plan
                                            of the Company or its parent and subsidiary corporations become exercisable for the first
                                            time by an optionee during any calendar year shall not exceed $100,000. To the extent that
                                            any Stock Option exceeds this limit, it shall constitute a Non-Qualified Stock Option.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>6.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>STOCK
                                            APPRECIATION RIGHTS</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Award
                                            of Stock Appreciation Rights</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Administrator may grant Stock Appreciation Rights under the Plan. A Stock Appreciation
                                            Right is an Award entitling the recipient to receive shares of Stock&nbsp;(or cash, to the
                                            extent explicitly provided for in the applicable Award Agreement) having a value equal to
                                            the excess of the Fair Market Value of a share of Stock on the date of exercise over the
                                            exercise price of the Stock Appreciation Right multiplied by the number of shares of Stock
                                            with respect to which the Stock Appreciation Right shall have been exercised.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Exercise
                                            Price of Stock Appreciation Rights</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The exercise price of a Stock Appreciation Right shall not be less than 100% of the Fair
                                            Market Value of the Stock on the date of grant.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(c)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Grant
                                            and Exercise of Stock Appreciation Rights</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Stock Appreciation Rights may be granted by the Administrator independently of any Stock
                                            Option granted pursuant to Section 5 of the Plan.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(d)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Terms
                                            and Conditions of Stock Appreciation Rights</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Stock Appreciation Rights shall be subject to such terms and conditions as shall be determined
                                            on the date of grant by the Administrator. The term of a Stock Appreciation Right may not
                                            exceed ten years. The terms and conditions of each such Award shall be determined by the
                                            Administrator, and such terms and conditions may differ among individual Awards and Grantees.</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

	<p class="ParaOverride-3" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-top: 0; margin-bottom: 0; margin-left: 36pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>7.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>RESTRICTED
                                            STOCK AWARDS</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Nature
                                            of Restricted Stock Awards</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Administrator may grant Restricted Stock Awards under the Plan. A Restricted Stock Award
                                            is any Award of Restricted Shares subject to such restrictions and conditions as the Administrator
                                            may determine at the time of grant. Conditions may be based on continuing employment (or
                                            other Service Relationship) and/or achievement of pre-established performance goals and objectives.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Rights
                                            as a Stockholder</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Upon the grant of the Restricted Stock Award and payment of any applicable purchase price,
                                            if any, a Grantee shall have the rights of a stockholder with respect to the voting of the
                                            Restricted Shares and receipt of dividends;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;that
                                            if the lapse of restrictions with respect to the Restricted Stock Award is tied to the attainment
                                            of performance goals, any dividends paid by the Company during the performance period shall
                                            accrue and shall not be paid to the Grantee until and to the extent the performance goals
                                            are met with respect to the Restricted Stock Award. Unless the Administrator shall otherwise
                                            determine, (i) uncertificated Restricted Shares shall be accompanied by a notation on the
                                            records of the Company or the transfer agent to the effect that they are subject to forfeiture
                                            until such Restricted Shares are vested as provided in Section 7(d) below, and (ii) certificated
                                            Restricted Shares shall remain in the possession of the Company until such Restricted Shares
                                            are vested as provided in Section 7(d) below, and the Grantee shall be required, as a condition
                                            of the grant, to deliver to the Company such instruments of transfer as the Administrator
                                            may prescribe.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(c)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Restrictions</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Restricted Shares may not be sold, assigned, transferred, pledged or otherwise encumbered
                                            or disposed of except as specifically provided herein or in the Restricted Stock Award Agreement.
                                            Except as may otherwise be provided by the Administrator either in the Award Agreement or,
                                            subject to Section 15, in writing after the Award is issued, if a Grantee&rsquo;s employment (or
                                            other Service Relationship) with the Company and its Subsidiaries terminates for any reason,
                                            any Restricted Shares that have not vested at the time of termination shall automatically
                                            and without any requirement of notice to such Grantee from or other action by or on behalf
                                            of, the Company be deemed to have been reacquired by the Company at their original purchase
                                            price (if any) from such Grantee or such Grantee&rsquo;s legal representative simultaneously with
                                            such termination of employment (or other Service Relationship), and thereafter shall cease
                                            to represent any ownership of the Company by the Grantee or rights of the Grantee as a stockholder.
                                            Following such deemed reacquisition of Restricted Shares that are represented by physical
                                            certificates, a Grantee shall surrender such certificates to the Company upon request without
                                            consideration.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(d)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Vesting
                                            of Restricted Shares</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Administrator at the time of grant shall specify the date or dates and/or the attainment
                                            of pre-established performance goals, objectives and other conditions on which the non-transferability
                                            of the Restricted Shares and the Company&rsquo;s right of repurchase or forfeiture shall lapse.
                                            Subsequent to such date or dates and/or the attainment of such pre-established performance
                                            goals, objectives and other conditions, the shares on which all restrictions have lapsed
                                            shall no longer be Restricted Shares and shall be deemed &ldquo;vested.&rdquo;</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>8.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>RESTRICTED
                                            STOCK UNITS</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Nature
                                            of Restricted Stock Units</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Administrator may grant Restricted Stock Units under the Plan. A Restricted Stock Unit
                                            is an Award of stock units that may be settled in shares of Stock (or cash, to the extent
                                            explicitly provided for in the Award Agreement) upon the satisfaction of such restrictions
                                            and conditions at the time of grant. Conditions may be based on continuing employment (or
                                            other Service Relationship) and/or achievement of pre-established performance goals and objectives.
                                            The terms and conditions of each such Award shall be determined by the Administrator, and
                                            such terms and conditions may differ among individual Awards and Grantees. Except in the
                                            case of Restricted Stock Units with a deferred settlement date that complies with Section
                                            409A, at the end of the vesting period, the Restricted Stock Units, to the extent vested,
                                            shall be settled in the form of shares of Stock (or cash, to the extent explicitly provided
                                            for in the Award Agreement). Restricted Stock Units with deferred settlement dates are subject
                                            to Section 409A and shall contain such additional terms and conditions as the Administrator
                                            shall determine in its sole discretion in order to comply with the requirements of Section
                                            409A.</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>


	<p class="ParaOverride-5" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-top: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Election
                                            to Receive Restricted Stock Units in Lieu of Compensation</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Administrator may, in its sole discretion, permit a Grantee to elect to receive a portion
                                            of future cash compensation otherwise due to such Grantee in the form of an award of Restricted
                                            Stock Units. Any such election shall be made in writing and shall be delivered to the Company
                                            no later than the date specified by the Administrator and in accordance with Section 409A
                                            and such other rules and procedures established by the Administrator. Any such future cash
                                            compensation that the Grantee elects to defer shall be converted to a fixed number of Restricted
                                            Stock Units based on the Fair Market Value of Stock on the date the compensation would otherwise
                                            have been paid to the Grantee if such payment had not been deferred as provided herein. The
                                            Administrator shall have the sole right to determine whether and under what circumstances
                                            to permit such elections and to impose such limitations and other terms and conditions thereon
                                            as the Administrator deems appropriate. Any Restricted Stock Units that are elected to be
                                            received in lieu of cash compensation shall be fully vested, unless otherwise provided in
                                            the Award Agreement.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(c)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Rights
                                            as a Stockholder</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            A Grantee shall have the rights as a stockholder only as to shares of Stock acquired by the
                                            Grantee upon settlement of Restricted Stock Units;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">,&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>however</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">,
                                            that the Grantee may be credited with Dividend Equivalent Rights with respect to the stock
                                            units underlying his or her Restricted Stock Units, subject to the provisions of Section
                                            10 and such terms and conditions as the Administrator may determine.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>9.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>UNRESTRICTED
                                            STOCK AWARDS</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
  Administrator may grant (or sell at par value or such higher purchase price determined by the Administrator) an Unrestricted Stock
  Award under the Plan. An Unrestricted Stock Award is an Award pursuant to which the Grantee may receive shares of Stock free of any
  restrictions under the Plan. Unrestricted Stock Awards may be granted in respect of past services or other valid consideration, or
  in lieu of cash compensation due to such Grantee.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>10.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>DIVIDEND
                                            EQUIVALENT RIGHTS</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Dividend
                                            Equivalent Rights</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Administrator may grant Dividend Equivalent Rights under the Plan. A Dividend Equivalent
                                            Right is an Award entitling the Grantee to receive credits based on cash dividends that would
                                            have been paid on the shares of Stock specified in the Dividend Equivalent Right (or other
                                            Award to which it relates) if such shares had been issued to the Grantee. A Dividend Equivalent
                                            Right may be granted hereunder to any Grantee as a component of an award of Restricted Stock
                                            Units or as a freestanding award. The terms and conditions of Dividend Equivalent Rights
                                            shall be specified in the Award Agreement. Dividend equivalents credited to the holder of
                                            a Dividend Equivalent Right may be paid currently or may be deemed to be reinvested in additional
                                            shares of Stock, which may thereafter accrue additional equivalents. Any such reinvestment
                                            shall be at Fair Market Value on the date of reinvestment or such other price as may then
                                            apply under a dividend reinvestment plan sponsored by the Company, if any. Dividend Equivalent
                                            Rights may be settled in cash or shares of Stock or a combination thereof, in a single installment
                                            or installments. A Dividend Equivalent Right granted as a component of an Award of Restricted
                                            Stock Units shall provide that such Dividend Equivalent Right shall be settled only upon
                                            settlement or payment of, or lapse of restrictions on, such other Award, and that such Dividend
                                            Equivalent Right shall expire or be forfeited or annulled under the same conditions as such
                                            other Award.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>11.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>TRANSFERABILITY
                                            OF AWARDS</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Transferability</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Except as provided in Section 11(b) below, during a Grantee&rsquo;s lifetime, his or her Awards
                                            shall be exercisable only by the Grantee, or by the Grantee&rsquo;s legal representative or guardian
                                            in the event of the Grantee&rsquo;s incapacity. No Awards shall be sold, assigned, transferred
                                            or otherwise encumbered or disposed of by a Grantee other than by will or by the laws of
                                            descent and distribution or pursuant to a domestic relations order. No Awards shall be subject,
                                            in whole or in part, to attachment, execution, or levy of any kind, and any purported transfer
                                            in violation hereof shall be null and void.</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

	<p class="ParaOverride-5" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-top: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Administrator
                                            Action</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Notwithstanding Section 11(a), the Administrator, in its discretion, may provide either in
                                            the Award Agreement regarding a given Award or by subsequent written approval that the Grantee
                                            (who is an Employee or director) may transfer his or her Non-Qualified Stock Options to his
                                            or her immediate family members, to trusts for the benefit of such family members, or to
                                            partnerships in which such family members are the only partners;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided&nbsp;</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">that
                                            the transferee agrees in writing with the Company to be bound by all of the terms and conditions
                                            of this Plan and the applicable Award. In no event may an Award be transferred by a Grantee
                                            for value.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(c)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Family
                                            Member</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            For purposes of Section 11(b), &ldquo;family member&rdquo; means a Grantee&rsquo;s child, stepchild, grandchild,
                                            parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law,
                                            father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive
                                            relationships, any person sharing the Grantee&rsquo;s household (other than a tenant of the Grantee),
                                            a trust in which these persons (or the Grantee) have more than 50% of the beneficial interest,
                                            a foundation in which these persons (or the Grantee) control the management of assets, and
                                            any other entity in which these persons (or the Grantee) own more than 50% of the voting
                                            interests.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(d)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Designation
                                            of Beneficiary</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            To the extent permitted by the Company, each Grantee to whom an Award has been made under
                                            the Plan may designate a beneficiary or beneficiaries to exercise any Award or receive any
                                            payment under any Award payable on or after the Grantee&rsquo;s death. Any such designation shall
                                            be on a form provided for that purpose by the Administrator and shall not be effective until
                                            received by the Administrator. If no beneficiary has been designated by a deceased Grantee,
                                            or if the designated beneficiaries have predeceased the Grantee, the beneficiary shall be
                                            the Grantee&rsquo;s estate.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>12.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>TAX
                                            WITHHOLDING</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Payment
                                            by Grantee</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Each Grantee shall, no later than the date as of which the value of an Award or of any Stock
                                            or other amount received thereunder first becomes includable in the gross income of the Grantee
                                            for income tax purposes, pay to the Company, or make arrangements satisfactory to the Administrator
                                            regarding payment of, any Federal, state, or local taxes of any kind required by law to be
                                            withheld by the Company with respect to such income. The Company and its Subsidiaries shall,
                                            to the extent permitted by law, have the right to deduct any such taxes from any payment
                                            of any kind otherwise due to the Grantee. The Company&rsquo;s obligation to deliver evidence of
                                            book entry (or stock certificates) to any Grantee is subject to and conditioned on tax withholding
                                            obligations being satisfied by the Grantee.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Payment
                                            in Stock</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Administrator may require the Company&rsquo;s tax withholding obligation to be satisfied, in
                                            whole or in part, by the Company withholding from shares of Stock to be issued pursuant to
                                            any Award a number of shares with an aggregate Fair Market Value (as of the date the withholding
                                            is effected) that would satisfy the withholding amount due;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">,&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>however</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">,
                                            that the amount withheld does not exceed the maximum statutory tax rate or such lesser amount
                                            as is necessary to avoid liability accounting treatment. For purposes of share withholding,
                                            the Fair Market Value of withheld shares shall be determined in the same manner as the value
                                            of Stock includible in income of the Grantees. The Administrator may also require the Company&rsquo;s
                                            tax withholding obligation to be satisfied, in whole or in part, by an arrangement whereby
                                            a certain number of shares of Stock issued pursuant to any Award are immediately sold and
                                            proceeds from such sale are remitted to the Company in an amount that would satisfy the withholding
                                            amount due.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>13.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>SECTION
                                            409A</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Awards
  granted under the Plan are intended to be exempt from Section 409A to the greatest extent possible and to otherwise comply with Section
  409A. The Plan and all Awards shall be interpreted in accordance with such intent. To the extent that any Award is determined to constitute
  &ldquo;nonqualified deferred compensation&rdquo; within the meaning of Section 409A (a &ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>409A
  Award</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&rdquo;),
  the Award shall be subject to such additional rules and requirements as specified by the Administrator from time to time in order to
  comply with Section 409A. In this regard, (a) a termination of the Service Relationship shall be deemed to occur with respect to a
  409 Award only if it is a &ldquo;separation from service&rdquo; within the meaning of Section 409A, and references in the Plan and the applicable
  Award Agreement to &ldquo;termination <font style="font-variant: normal">of the Service Relationship&rdquo; or similar terms means a &ldquo;separation
  from service&rdquo;; and (b) if any amount under a 409A Award is payable upon a &ldquo;separation from service&rdquo; (within the meaning of Section
  409A) to a Grantee who is then considered a &ldquo;specified employee&rdquo; (within the meaning of Section 409A), then no such payment shall be
  made prior to the date that is the earlier of (i) six months and one day after the Grantee&rsquo;s separation from service, or (ii) the Grantee&rsquo;s
  death, but only to the extent such delay is necessary to prevent such payment from being subject to interest, penalties or additional
  tax imposed pursuant to Section 409A. Further, the settlement of any 409A Award may not be accelerated except to the extent permitted
  by Section 409A. The Company makes no representation that any or all of the payments or benefits described in the Plan will be exempt
  from or comply with Section 409A of the Code and makes no undertaking to preclude Section 409A of the Code from applying to any such
  payment. The Grantee shall be solely responsible for the payment of any taxes and penalties incurred under Section 409A.</font></font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>




	<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-top: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>


<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>14.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>TERMINATION
                                            OF SERVICE RELATIONSHIP</b></font></td>
</tr></table>
		<p class="ParaOverride-5" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Termination
                                            other than for Cause</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Except to the extent inconsistent with the terms of an applicable Award Agreement or the
                                            provisions of Section 14(b), the following terms and conditions shall apply with respect
                                            to a termination of a Grantee&rsquo;s Service Relationship with the Company or an Affiliate, as
                                            applicable:</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(i)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
                                            Grantee&rsquo;s rights, if any, to exercise any then exercisable Options or Stock Appreciation
                                            Rights shall terminate:</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(1)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">If
                                            such termination is for a reason other than the Grantee&rsquo;s Total and Permanent Disability
                                            or death, 90 days after the date of such termination of the Service Relationship;</font></td>
</tr></table>

<p class="ParaOverride-9" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 144pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(2)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">If
                                            such termination is on account of the Grantee&rsquo;s Total and Permanent Disability, one year
                                            after the date of such termination of the Service Relationship; or</font></td>
</tr></table>

<p class="ParaOverride-9" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 144pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(3)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">If
                                            such termination is on account of the Grantee&rsquo;s death, one year after the date of the Grantee&rsquo;s
                                            death.</font></td>
</tr></table>

<p class="ParaOverride-9" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 144pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="Text_flush" style="border-width: 0; margin: 0; font: normal 10pt Times New Roman PS Std, serif; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; page-break-after: auto; page-break-before: auto; text-align: justify; text-indent: 0; widows: 3; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
  such applicable date the Grantee (and such Grantee&rsquo;s estate, designated beneficiary or other legal representative) shall forfeit any
  rights or interests in or with respect to any such Options and Stock Appreciation Rights. Notwithstanding the foregoing, the Administrator,
  in its sole discretion, may provide for a different time period in the Award Agreement, or may extend the period, following a termination
  of the Service Relationship, during which the Grantee has the right to exercise any vested Non-qualified Stock Option or Stock Appreciation
  Right, which period may not extend beyond the expiration date of the Award term.</font></p>

<p class="Text_flush" style="border-width: 0; font: normal 10pt Times New Roman PS Std, serif; margin: 0pt 0 0; padding: 0; orphans: 2; page-break-after: auto; page-break-before: auto; text-align: justify; text-indent: 0; widows: 3"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(ii)</font></td><td style="text-align: justify"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">In
                                            the event of a termination of a Grantee&rsquo;s Service Relationship for any reason prior to the
                                            actual or deemed satisfaction and/or lapse of the vesting requirements, restrictions, terms
                                            and conditions applicable to a Restricted Stock Award, Restricted Stock Unit Award or Dividend
                                            Equivalent Right, such Award shall immediately be canceled, and the Grantee (and such Grantee&rsquo;s
                                            estate, designated beneficiary or other legal representative) shall forfeit any rights or
                                            interests in and with respect to any such Award.</font></td>
</tr></table>

<p class="ParaOverride-6" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 108pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Termination
                                            for Cause</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Notwithstanding anything in this Section 14 or elsewhere in the Plan to the contrary, and
                                            unless a Grantee&rsquo;s Award Agreement specifically provides otherwise, in the event of a termination
                                            of a Grantee&rsquo;s Service Relationship for Cause, all of such Grantee&rsquo;s then-outstanding Awards
                                            shall expire immediately and be forfeited in their entirety upon such termination of the
                                            Service Relationship.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>15.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>AMENDMENTS
                                            AND TERMINATION</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
		<p class="Text_flush" style="border-width: 0; margin: 0; font: normal 10pt Times New Roman PS Std, serif; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; page-break-after: auto; page-break-before: auto; text-align: justify; text-indent: 0; widows: 3; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
  Board may, at any time, amend, suspend, discontinue or terminate the Plan and the Administrator may, at any time, amend or cancel any
  outstanding Award for the purpose of satisfying changes in law or for any other lawful purpose;&nbsp;<font class="CharOverride-8" style="font-weight: normal"><i>provided</i></font></font><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;that
  no such action shall materially and adversely affect rights under any outstanding Award without the affected Grantee&rsquo;s consent. Except
  as provided in Section 3(b) or 3(c), without prior approval by the holders of a majority of the shares of the Company&rsquo;s securities
  entitled to vote generally in the election of directors, in no event may the Administrator or the Board reduce the exercise price of
  outstanding Stock Options or Stock Appreciation Rights, whether by amendment or otherwise, or effect repricing through cancellation
  and re-grants or cancellation of Stock Options or Stock Appreciation Rights in exchange for cash or other Awards. To the extent required
  under the rules of any securities exchange or market system on which the Stock is listed, to the extent determined by the Administrator
  to be required by the Code to ensure that Incentive Stock Options granted under the Plan are qualified under&nbsp;Section 422&nbsp;of
  the Code, Plan amendments shall be subject to approval by Company stockholders. Nothing in this Section 15 shall limit the Administrator&rsquo;s
  authority to take any action permitted pursuant to Section 3(b) or 3(c).</font></p>




	<p class="Text_flush" style="border-width: 0; margin: 0; font: normal 10pt Times New Roman PS Std, serif; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; page-break-after: auto; page-break-before: auto; text-align: justify; text-indent: 0; widows: 3; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p class="Text_flush" style="border-width: 0; font: normal 10pt Times New Roman PS Std, serif; margin: 0pt 0 0; padding: 0; orphans: 2; page-break-after: auto; page-break-before: auto; text-align: justify; text-indent: 0; widows: 3"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="Text_flush" style="border-width: 0; font: normal 10pt Times New Roman PS Std, serif; margin: 0pt 0 0; padding: 0; orphans: 2; page-break-after: auto; page-break-before: auto; text-align: justify; text-indent: 0; widows: 3"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>


<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>16.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>STATUS
                                            OF PLAN</b></font></td>
</tr></table>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">With
respect to the portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by
a Grantee, a Grantee shall have no rights greater than those of a general creditor of the Company unless the Administrator shall otherwise
expressly determine in connection with any Award or Awards. In its sole discretion, the Administrator may authorize the creation of trusts
or other arrangements to meet the Company&rsquo;s obligations to deliver Stock or make payments with respect to Awards hereunder;&nbsp;</font><font class="CharOverride-5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><i>provided&nbsp;</i></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">that
the existence of such trusts or other arrangements is consistent with the foregoing sentence.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>17.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>GENERAL
                                            PROVISIONS</b></font></td>
</tr></table>

<p class="ParaOverride-3" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 36pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>No
                                            Distribution</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Administrator may require each person acquiring Stock pursuant to an Award to represent
                                            to and agree with the Company in writing that such person is acquiring the shares without
                                            a view to distribution thereof.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Issuance
                                            of Stock</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            To the extent certificated, stock certificates to Grantees under this Plan shall be deemed
                                            delivered for all purposes when the Company or a stock transfer agent of the Company shall
                                            have mailed such certificates in the United States mail, addressed to the Grantee, at the
                                            Grantee&rsquo;s last known address on file with the Company. Uncertificated Stock shall be deemed
                                            delivered for all purposes when the Company or a Stock transfer agent of the Company shall
                                            have given to the Grantee by electronic mail (with proof of receipt) or by United States
                                            mail, addressed to the Grantee, at the Grantee&rsquo;s last known address on file with the Company,
                                            notice of issuance and recorded the issuance in its records (which may include electronic
                                            &ldquo;book entry&rdquo; records). Notwithstanding anything herein to the contrary, the Company shall
                                            not be required to issue or deliver any evidence of book entry or certificates evidencing
                                            shares of Stock pursuant to the exercise or settlement of any Award, unless and until the
                                            Administrator has determined, with advice of counsel (to the extent the Administrator deems
                                            such advice necessary or advisable), that the issuance and delivery is in compliance with
                                            all applicable laws, regulations of governmental authorities and, if applicable, the requirements
                                            of any exchange on which the shares of Stock are listed, quoted or traded. Any Stock issued
                                            pursuant to the Plan shall be subject to any stop-transfer orders and other restrictions
                                            as the Administrator deems necessary or advisable to comply with federal, state or foreign
                                            jurisdiction, securities or other laws, rules and quotation system on which the Stock is
                                            listed, quoted or traded. The Administrator may place legends on any Stock certificate or
                                            notations on any book entry to reference restrictions applicable to the Stock. In addition
                                            to the terms and conditions provided herein, the Administrator may require that an individual
                                            make such reasonable covenants, agreements, and representations as the Administrator, in
                                            its discretion, deems necessary or advisable in order to comply with any such laws, regulations,
                                            or requirements. The Administrator shall have the right to require any individual to comply
                                            with any timing or other restrictions with respect to the settlement or exercise of any Award,
                                            including a window-period limitation, as may be imposed in the discretion of the Administrator.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(c)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>No
                                            Fractional Shares</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            No fractional shares of Stock shall be issued or delivered pursuant to the Plan or any Award,
                                            and the Administrator shall determine whether cash, other securities or other property shall
                                            be paid or transferred in lieu of any fractional shares, or whether such fractional shares
                                            or any rights thereto shall be canceled, terminated or otherwise eliminated.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(d)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Stockholder
                                            Rights</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Until Stock is deemed delivered in accordance with Section 17(b), no right to vote or receive
                                            dividends or any other rights of a stockholder will exist with respect to shares of Stock
                                            to be issued in connection with an Award, notwithstanding the exercise of a Stock Option
                                            or any other action by the Grantee with respect to an Award.</font></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>



	<p class="ParaOverride-5" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-top: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(e)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Other
                                            Compensation Arrangements; No Employment Rights</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Nothing contained in this Plan shall prevent the Board from adopting other or additional
                                            compensation arrangements, including trusts, and such arrangements may be either generally
                                            applicable or applicable only in specific cases. The adoption of this Plan and the grant
                                            of Awards do not confer upon any Employee any right to continued employment with the Company
                                            or any Subsidiary.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(f)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Trading
                                            Policy Restrictions</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Option exercises and other Awards under the Plan shall be subject to the Company&rsquo;s insider
                                            trading policies and procedures, as in effect from time to time.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(g)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Rule
                                            16b-3</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Company intends that the Plan and any Award made to a person subject to Section 16 of
                                            the Exchange Act satisfy, and ben interpreted in a manner that satisfies, the applicable
                                            requirements of Rule&nbsp;16b-3. If the operation of any provision of the Plan or of any
                                            such Award would conflict with this intent or otherwise not comply with the requirements
                                            of Rule 16b-3, such provision or Award shall, to the extent possible, be interpreted and/or
                                            deemed to have been amended so as to avoid such conflict and/or noncompliance.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(h)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Clawback
                                            Policy</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            A participant&rsquo;s rights with respect to any Award hereunder shall in all events be subject
                                            to reduction, cancellation, forfeiture or recoupment to the extent necessary to comply with
                                            (i) any right that the Company may have under any Company clawback, forfeiture or recoupment
                                            policy as in effect from time to time or other agreement or arrangement with a Grantee, or
                                            (ii) applicable law.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(i)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>No
                                            Obligation to Notify or Minimize Taxes</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Company shall have no duty or obligation to any Grantee to advise such Grantee as to
                                            the time or manner of exercising any Award. Furthermore, the Company shall have no duty or
                                            obligation to warn or otherwise advise such Grantee of a pending termination or expiration
                                            of an Award or a possible period in which the Award may not be exercised. The Company has
                                            no duty or obligation to minimize the tax consequences of an Award to any person.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(j)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Notification
                                            of Election Under Section 83(b) of the Code</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            If any Grantee, in connection with the acquisition of Stock under an Award, makes the election
                                            permitted under Section 83(b) of the Code, if applicable, the Grantee shall notify the Company
                                            of the election within 10 days of filing notice of the election with the Internal Revenue
                                            Service.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(k)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Paperless
                                            Administration</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            If the Company establishes, for itself or using the services of a third party, an automated
                                            system for the documentation, granting or exercise of Awards, such as a system using an internet
                                            website or interactive voice response, then the paperless documentation, granting or exercise
                                            of Awards by a Grantee may be permitted through the use of such an automated system.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(l)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Broker-Assisted
                                            Sales</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            In the event of a broker-assisted sale of Stock in connection with the payment of amounts
                                            owed by a Grantee under or with respect to the Plan or Awards: (i) any Stock to be sold through
                                            the broker-assisted sale will be sold on the day the payment first becomes due, or as soon
                                            thereafter as practicable; (ii) the Stock may be sold as part of a block trade with other
                                            Grantees in the Plan in which all participants receive an average price; (iii) the applicable
                                            Grantee will be responsible for all broker&rsquo;s fees and other costs of sale, and by accepting
                                            an Award, each Grantee agrees to indemnify and hold the Company harmless from any losses,
                                            costs, damages or expenses relating to any such sale; (iv) to the extent the Company or its
                                            designee receives proceeds of the sale that exceed the amount owed, the Company will pay
                                            the excess in cash to the applicable Grantee as soon as reasonably practicable; (v) the Company
                                            and its designees are under no obligation to arrange for the sale at any particular price;
                                            and&nbsp;(vi) if&nbsp;the proceeds of the sale are insufficient to satisfy the Grantee&rsquo;s
                                            applicable obligation, the Grantee may be required to pay immediately upon demand to the
                                            Company or its designee an amount in cash sufficient to satisfy any remaining portion of
                                            the Grantee&rsquo;s obligation.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(m)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Data
                                            Privacy</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            As a condition for receiving any Award, each Grantee explicitly and unambiguously consents
                                            to the collection, use and transfer, in electronic or other form, of personal data as described
                                            in this Section 17(h) by and among the Company and its Subsidiaries and Affiliates exclusively
                                            for implementing, administering and managing the Grantee&rsquo;s participation in the Plan. The
                                            Company and its Subsidiaries and Affiliates may hold certain personal information about a
                                            Grantee, including the Grantee&rsquo;s name, address and telephone number; birthdate; social security,
                                            insurance number or other identification number; salary; nationality; job title(s); any Stock
                                            held in the Company or its Subsidiaries and Affiliates; and Award details, to implement,
                                            manage and administer the Plan and Awards (the &ldquo;</font><font class="CharOverride-4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Data</i></b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&rdquo;).
                                            The Company and its Subsidiaries and Affiliates may transfer the Data amongst themselves
                                            as necessary to implement, administer and manage a Grantee&rsquo;s participation in the Plan, and
                                            the Company and its Subsidiaries and Affiliates may transfer the Data to third parties assisting
                                            the Company with Plan implementation, administration and management. These recipients may
                                            be located in the Grantee&rsquo;s country, or elsewhere, and the Grantee&rsquo;s country may have different
                                            data privacy laws and protections than the recipients&rsquo; country. By accepting an Award, each
                                            Grantee authorizes the recipients to receive, possess, use, retain and transfer the Data,
                                            in electronic or other form, to implement, administer and manage the Grantee&rsquo;s participation
                                            in the Plan, including any required Data transfer to a broker or other third party with whom
                                            the Company or the Grantee may elect to deposit any Stock. The Data related to a Grantee
                                            will be held only as long as necessary to implement, administer, and manage the Grantee&rsquo;s
                                            participation in the Plan. A Grantee may, at any time, view the Data that the Company holds
                                            regarding the Grantee, request additional information about the storage and processing of
                                            the Data regarding the Grantee, recommend any necessary corrections to the Data regarding
                                            the Grantee or refuse or withdraw the consents in this Section 17(h) in writing, without
                                            cost, by contacting the local human resources representative. The Company may cancel Grantee&rsquo;s
                                            ability to participate in the Plan and, in the Administrator&rsquo;s discretion, the Grantee may
                                            forfeit any outstanding Awards if the Grantee refuses or withdraws the consents in this Section
                                            17(h).</font></td>
</tr></table>




	<p class="ParaOverride-7" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(n)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Severability
                                            of Provisions</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            If any provision of the Plan is held invalid or unenforceable, such invalidity or unenforceability
                                            shall not affect any other provision of the Plan, and the Plan shall be construed and enforced
                                            as if such invalid or unenforceable provision had not been included in the Plan.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(o)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>No
                                            Funding</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            The Plan shall be unfunded, and the Company shall not be required to establish any special
                                            or separate fund or to make any other segregation of funds or assets to ensure the payment
                                            of any Award. Prior to receipt of shares of Stock or a cash distribution under the terms
                                            of an Award, such Award shall represent an unfunded unsecured contractual obligation of the
                                            Company and the Grantee shall have no greater claim to the shares of Stock underlying such
                                            Award or any other assets of the Company or Affiliate than any other unsecured general creditor.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(p)</font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>Headings</b></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">.
                                            Headings used throughout the Plan are for convenience only and shall not be given legal significance.</font></td>
</tr></table>

<p class="ParaOverride-5" style="border-width: 0; padding: 0; margin-bottom: 0; margin-left: 72pt; orphans: 2; text-align: justify; text-indent: -36pt; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>18.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>EFFECTIVE
                                            DATE AND TERM OF PLAN</b></font></td>
</tr></table>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">This
  Plan shall be effective upon the Effective Date, subject to the Plan being approved by the Company&rsquo;s stockholders within 12 months
  of the date of the Plan&rsquo;s adoption in accordance with applicable state law and applicable stock exchange rules. No Award may be granted
  after the 10</font><font class="CharOverride-9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><sup>th</sup></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;anniversary
  of the Effective Date and no Incentive Stock Option may be granted after the 10</font><font class="CharOverride-9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal"><sup>th</sup></font><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;anniversary
  of the earlier of the date of the Board&rsquo;s adoption of the Plan and the date of stockholder approval.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
<table cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>19.</b></font></td><td style="text-align: justify"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><b>GOVERNING
                                            LAW</b></font></td>
</tr></table>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><b>&nbsp;</b></font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
  law of the State of Delaware shall govern all questions concerning the construction, validity and interpretation of this Plan, without
  regard to such state&rsquo;s conflict of law rules.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">As
  adopted by the Board of Directors of TRILLER GROUP INC., on _____.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>
		<p class="ParaOverride-4" style="border-width: 0; margin-top: 0; padding: 0; margin-bottom: 0; margin-top: 0pt; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">As
  approved by the stockholders of TRILLER GROUP INC., on ______.</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"></p>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></div>
    <!-- Field: /Page -->

<p class="ParaOverride-4" style="border-width: 0; padding: 0; margin-bottom: 0; orphans: 2; text-align: justify; widows: 2; margin-top: 0pt"><font class="CharOverride-3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</font></p>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>illr-20260610.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaONOaPtyJ1x6YkxuG93fbmaXyAlKuSntSxC+UsmQfsP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:srt-types="http://fasb.org/srt-types/2026" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ILLR="http://agba.com/20260610" elementFormDefault="qualified" targetNamespace="http://agba.com/20260610">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://agba.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="illr-20260610_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="illr-20260610_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="illr-20260610_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd" />
    <import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd" />
    <import namespace="http://fasb.org/us-types/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2026" schemaLocation="https://xbrl.sec.gov/country/2026/country-2026.xsd" />
    <import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd" />
    <import namespace="http://fasb.org/srt-types/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd" />
    <element id="ILLR_CommonStock0.001ParValueMember" name="CommonStock0.001ParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" name="WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>illr-20260610_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="illr-20260610.xsd#Cover" roleURI="http://agba.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://agba.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="illr-20260610.xsd#ILLR_CommonStock0.001ParValueMember" xlink:label="loc_ILLRCommonStock0.001ParValueMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ILLRCommonStock0.001ParValueMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="illr-20260610.xsd#ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" xlink:label="loc_ILLRWarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ILLRWarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>illr-20260610_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="illr-20260610.xsd#ILLR_CommonStock0.001ParValueMember" xlink:label="ILLR_CommonStock0.001ParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ILLR_CommonStock0.001ParValueMember" xlink:to="ILLR_CommonStock0.001ParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ILLR_CommonStock0.001ParValueMember_lbl" xml:lang="en-US">Common Stock, $0.001 par value</link:label>
      <link:loc xlink:type="locator" xlink:href="illr-20260610.xsd#ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" xlink:label="ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" xlink:to="ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember_lbl" xml:lang="en-US">Warrants, each warrant exercisable for one-quarter of one share of Common Stock for $23.00 per full share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>illr-20260610_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="illr-20260610.xsd#Cover" roleURI="http://agba.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://agba.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="illr-20260610.xsd#ILLR_CommonStock0.001ParValueMember" xlink:label="loc_ILLRCommonStock0.001ParValueMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ILLRCommonStock0.001ParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="illr-20260610.xsd#ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" xlink:label="loc_ILLRWarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ILLRWarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 10, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 10,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TRILLER GROUP INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001769624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-1473901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1301 N Broadway, STE 98065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">622-9043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ILLR_CommonStock0.001ParValueMember', window );">Common Stock, $0.001 par value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ILLR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember', window );">Warrants, each warrant exercisable for one-quarter of one share of Common Stock for $23.00 per full share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each warrant exercisable for one-quarter of one share of Common Stock for $23.00 per full share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ILLRW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ILLR_CommonStock0.001ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ILLR_CommonStock0.001ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea0294347-8k_triller.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://agba.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0294347-8k_triller.htm">ea0294347-8k_triller.htm</File>
    <File>illr-20260610.xsd</File>
    <File>illr-20260610_def.xml</File>
    <File>illr-20260610_lab.xml</File>
    <File>illr-20260610_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0294347-8k_triller.htm": {
   "nsprefix": "ILLR",
   "nsuri": "http://agba.com/20260610",
   "dts": {
    "inline": {
     "local": [
      "ea0294347-8k_triller.htm"
     ]
    },
    "schema": {
     "local": [
      "illr-20260610.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "illr-20260610_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "illr-20260610_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "illr-20260610_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2026": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2026": 25
   },
   "report": {
    "R1": {
     "role": "http://agba.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-06-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0294347-8k_triller.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-06-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0294347-8k_triller.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "auth_ref": []
    },
    "ILLR_CommonStock0.001ParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://agba.com/20260610",
     "localname": "CommonStock0.001ParValueMember",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, $0.001 par value"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CountryRegion",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Extension",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12gTitle",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementLineItems",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementTable",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ILLR_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://agba.com/20260610",
     "localname": "WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each warrant exercisable for one-quarter of one share of Common Stock for $23.00 per full share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://agba.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001213900-26-067658-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-067658-xbrl.zip
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M  "L"P0 %0   &5A,#(Y-#,T-S Q97@Q,"TQ+FAT;>V]Z7+;5M8V^KM3E7O
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M%,@/:_[DH+16*:WU?ZS!JM;+(#CWCO8I%9SB<H=), EE4C%F4R6LX=B$18:
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MC#'.^MYUU^$8W$MSQFU008,*:JJ@Z#&J( >L%QBRQ3 ALSJ6Q1P^:>!)24+
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M(\[$ XD.6^BK[8"M$1NC5FTK%;T1BP"=<;BOQ>,T>M:OS!%I*G\JG"X[*]G
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M]R* C@Y_'"30((&^O@3:5A%49GY'WY(SW4Q%JB4 INJY"$J7A32ZB>AJ;<=
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M=#S26U2DL79$KSETH0!'H^ZL%0VU<615(L,W<V1*DZV,(,KBC"N"UY0772+
M;R KY,7!RK5:ME*%"\[QCL,;;FU8)L?'5$TV5'.!F/<O$N,M*>2^(]:#;VI!
M]XB^P7IR[!T4RR+*!0V24IPQ(U'<9FS,..CT",%E[+M9MZ72>547Y!7>?/]*
MYQ_<TN$'KG0^.AQ*G7$&C@YWJ=;9+PBU9JWS5]NV&V/D;WM'X6WS=M<+$FY)
M\<E)TD=Q@D(^5RR_2VP8T-WOI*A0-6.F0:0%>0L[ZR6/EA@Q(]70R4GOP^2)
M1,&:-%=R&,RSO!=V=U)1<H::(T?.3#NPK;AJHW :]C!V&&D79/8A"J+E/PB.
M-6)8J UF3?)9&(L:AJN>ZB#PL2V44'DJOZ%@<B5D9%CH4 8I--TR]!IAMMH-
M\5R;V=]QITE0?>VJ1&5VG$["KG_<S61DIM)9:E]TA[,O3*<UO15HA0I&?D\,
MSH>[#:)LY[4(@XG\#+]:TNA[V"<V1K&41+M-88J_U)[H)JN2N&_9AL6'=56N
MR$8OY6D8*W0H?,&X:"Z(G[&9Q AU!SJG9LD9215.T=(Z:<_I9LI=V7%3<2CN
MAAQYF4?5#'86;&+/8!,V(F2)53N^A2[?D3.$J?*;U"<GM&_S-N]T&@E'YBO>
MNCQ-2H866.R79W-0Q*7@$[)$#QG$%CT(;^6Q?TD-MQ$%X9 HI=:6M^;88!O,
MA0Y;P*I0L9&5QDZYAS_K?!/7.V1_A^SO3AO;VUHG,=1TT\_Q+37432 O*'J0
MG2%9(\T8;0.][3<04XJ*.1HGI+HT8C[45-^^&4:;,4?3[$9<XWG9Q"GRU?$-
MXUSE\L";!$M*J%;3;U2I=W ")^(:>R:6FI.UJPZZ\.>WKFQR-UF@DX9M$<'X
M0OMN6=K&J=:A0MI:)^Y>\?FCPUM833L-Q!JASV A#1;25N/C?MH:?-S'LX%(
M<;LA<G]9EF!<T36^3X+1(RVSF7*P*?%4L&<9=@K1!87 8LL26RZKWG.Z&' *
MU\*>SC7.HMMP*@BY <6;-W0QC8)B!"U@5M?';=6LP5NYK2QL/8)KCBSI[Q=,
M<B$4%Q,.HP:6;XYFV5!:73QD:JP9!!2%10DS20BDPA:1PGS*N%[#-@H8E+ R
M9-,1&#]HYM&\#\3J$["E&WY0_%]=G1X=;HWF?W/ZS],W)V>>6O_D'Q]/_WG\
M[N3L<FC'_."J?[O.Z7:',+<#':^##)Z'NAF1V(4HYBI<_(I83!L;W_'A^VW$
M[& ,M)G&H2,GU4IVD&4+I) 3I5#OE#C5T/>&46A3[@IQL'2^+!^%9XB9IL%8
MJ[*$)\?D?[%OLK=J4)B\I0$S14PCUWN/Z].P83'UJ?9"1OP7-1H+M$BSU/"8
M=N$P^G2HX_1GEO--T#;'='!,@ NF05P%GU^^J_OBL)O[H)G)M+<4YI:%C7NJ
MM=)9 D^&F'#%ME.+19LX(LX-:@V8ZS<LE0Q1[LE4,>L@4L0@I;UGQ3TD([5U
M\88.WXIFV+1P;&=F'%B('I-_X;JEH"R[P!?U9EON;8SOROX7>ZR*+@I>\4WS
MSQ':S2<D-)*I?L,Y2%#81+ ]LS:!STAQ]A[<TP$V7JA3/4!2DX$9-0&')PS/
M\%B3[##284* L# HX, E@G@38:Y[< OD[G>+)4)*;64M<#KE2@?A?G_<#N\<
ME9QB%4+[8?G86A49E.G#=)SGGG5R=[E# 8T._Q*67HP&.+N5)D*S&S4'?C=K
M1SVE^#R7.05XQD(S*#!57)BF58)/;VV#(IR)9I\\&%&?VBSFMQTR'D/@8ZL#
M'T=;$_BX/#\^NWA[<G[\V^F[T\M_>_80?CND/(:XQQ#WV+0S7:==VH7XA>5S
M[>(:/SK:&QNR<=4GH,V<FLB)P)+SD0L%X9Q-3Z=#<,MZ.G]D#-;9'\F@J[^T
MFB\3/GY5P7C@Z'O2#;"C(ZZ%;3O2O*-,HQ#E00E.QEFFDU76J%U.%>QM[W?1
M"3<9@JE/@*')9-@UECJ,L406>QB8J4O"F\+;7XY%$3%99XRW!5-Z7'%125Y+
M$(*WELVPLCOBH N;VZB)NF>)$4*^_5B0@@OQ[UQ*/0]SYJE'IK!HBN;_"/=2
M5.F\'VR/ZX7N"O,)-!8;^_@7#!X+;="?5ROD/99KF?&3!NSHV<=#TY[N=)W)
M=<SPC:@K7M5!>??KBH^&NF*J*SX:ZHHW9=M^R<,^V+M?T][=C@K@._!X'$>[
M4M-[EI6(G#8I$L<V#O='731!JMS7K?3E%C8<$C6=$.Y<XP66U15:M6257X&A
M:T*Y9.,5EEL5"VI+>)MJXZZ1OJ6!)O<;RQY872K5>$*T4<S('LL<)@<1:!3M
MUQV '*_@+$N?_*."_4WY'@X;OY^K.L ,/^EM$]-<SF8BQH*_@'=/,!-H'"O"
MH!S.$;=5P <>BU1,I*60;7X#/Y9YDON#W:EHZPNV2:6FF*I?G<H-<1#DU.BO
M;5@]B1[-!I9,^/?H<SN;85H5CT[AEIBWVG-P-F^<52GW7$.7B1V_KHQH#^IE
M. V8]#=TRTYS2M6%[C3%,G5V.O$DF13-6+CN8\W5\^>>(JCID!(84@*/S/;:
MCC+1MW0YOU/]!VF973"ZWG(T"8-:;HT8!R1'FNZ\IEP5Z3G\%6*JM!6FBZ82
M W%%*>;J5\R)Q_R[M[ZGT!)>2_].%S-OS+.J$"/B4$':#/5G(<<(QQH%J101
M_)V*^53<@'5(8;HG*!?#&\^Q3$+WNT$!!I;^/0XK6 /GS7%>NQ%A%L!L=5Z1
M:914;%#&V1QCI[Y\");Z4S6?G8.%PQP(>0.*9I9FBM.#^)U@SPE8AB!&TK 5
M=]WW[8C%!J"UR^!:A5##*@A:YEZ=P6NSC PU&,6+P[_J ;#E&$DPGR5&743A
M&Z\,84> 71%J#L.U!H0,C'F6T(MP)L,K4YX,QUJ410]>4NJT1#--&,'%VF/)
M;M+NN>%FUKX14Y[$8C!"!B/DD1DAV]%5Z(W K%78BWWL-RTM\YU(E%[6R'^9
M!ZGL@!L2N[2#M;Z99C/KP$W#@G'&Q'1&2"]_?Y:\1RYEY^5!DKBQG6Y&E^D_
M)3>%4RE50;+?1(D,R9POC9I&UREHIKDFO*ZRMH1I,STXFRH_%F"W.$C5V.ZT
M/BWGQW3'D$GK:HSL%.A2IN1R;K=:GWKN>8[30GV]>S)"=3.VG6+SR]IBF2UA
M5E,Y]K&@AHJ&!-S3UL"4*.MF]\*U;4&FSCP7YDZU''O-Y(&!ZF2F_X9MM5HM
M2B3G&K3^H/6W&HWX='O0B,?_G]^Q_=?IY=___O[=F].SWP<,XH!!? PF^79@
M$#^PX>5I'IG"LETPQ4]<$YNLDM$R6M^0HH>6K.):<\>&3JI4P<%Z5-+97N6S
MK*)\K#+^2EO8-Y%Y@69EA' X%6"C0ZVPA5=Y5M#KF>K#WC<IR_U$Z#)E^-F$
M3T=HDS<HDT=<Q/8))BB'6UVI9AFF.5&6FV_< 0-@L]-N+0Y.]5N!9!P)1E!A
ME1B8ET68E@X_<\!7X_-T-P^RB9/PI@])*Z;XIB)I]79O$J*1(\(SR"60I@D\
MLC_#_&"S4ADKXYDWGC>#[C(GDL*O=0Y$YO.-JXA;HS/7&4T0M8^GX&H?:>!.
M;XL*O%;VZDR",=ZS,4A"5<^6:5+N0%"-5"2\\:3C+/N$44C8<<2%0Y  MZ/Y
M?K,T5A8NGUPM':L(HV'WTYIG2>S?$]D\'KIEU B>3H5##=[B@QG\E\%_>10F
MTG; UGJ92%CU@+)G%PRD;E(*I4D[6WPW1&9#R(^%%8(C;^!:&Z'?H8?UC4FS
M-0NI>0B*FL$I,O!/>K'-%SJM"M2]N E>&H175VBVE%TM!_;8FJQU&^BM9T"+
M<9Q1Q/L.T8::Z$7SXMK"!"V]87"QC02*#?3#7XQ^6&U$8U3'&8P/(^?B<R14
M#'D6?I:S:D;F?<7>! B8G.@B%#T$MCXPCI,W&SJ<GA1\K:((V5,)L:XF2*2J
MS*-&+1B\1\!!+L*2>42:J!(Z^^XI\YZ3)9U)S.0HZ=+58E3JAK S2NNG(M><
MQ>2D>IOT+"H5@$/YEYU>97&P1$&$29&MTA*>D^.E4KJU! IDZZ!B2Y-<C#TS
M52%Y$]C"LB7T[:RU5(NK+6 V#, X65!!GS_D@OKZB%CY;LP]%":"KIX+Y0?6
MO72B"4GU@;M=1WC.BU$H@R,S.#+;G8AYMC6)F(N3UY>G[\_\F]$.69B!_'KC
MN8";4LZ2 &C^J3KQ(>M6>".-#8^:^"QF\Y+59*TGM5*.5VC/B:(T4=2L*,C>
M45W(;$33;0SM-)F@ULYD IDR#+3.FA7IA$Z<YT(3NC5:_ZE@<4F&91T<Q(W%
MC/T@"]?LHX;5*:PB&,9DY"DL<YJE?YK"*-,^SN6DU@!GO+TR'A'K3+;5I#Y5
M>Z&^[*UNQ_/[V!)T>,#?T7T0Z<'9Z]G :(J:2 82V[*Z)A>!20DX-'NV3V.M
MRS@2<ZUN($G;&4DR:!OCOTX+<QQ'QV95._4TY:(A3J>,8''W"1N-&XKM:67?
M7S#[>7#N@+!=UT.3%6915.6M[$>HSH;.BV&%FIP@:286^NG]5 @PSOFN;,CR
M/=??FR,U>UB/A2T(M1^TI"3*LM;;JD<8K!J-.PGMZNB6A%\Q3_H!"!(/^R_4
MS0IU.4'K^7%D'5/PBAX":5.8>%#;V9K#D,ZG$0P:+D>]I]:=Y+V5LZQ%'.=-
M3-9$56PB!:.APT<^0'-/LW^%JNA<[W9\KQ%?.,WJ/3%=R!@A'N>YI/I*-X@6
MEFI@@0CS1+*'MB?W82$^!S-8R*EJ(9GB5Q8K0(5+YHWRBWM2[G=]"8=&8$1P
M.*N2MWT]3:?PB0G<NAEV /5P;3ZB'YINK5)'5I*8BH$ !'J8E)*[%-1Y0M%G
MYBZ:=6>T+A#>5CGJ.$;HU1N6X89S=AAZ]0K4"/I+)-@! 5>827^69"-Q("##
MZO=TTZ&8.,:03XUE1[>/I=*"W"V;5/-26%@J%D>+(LKEV,9!Z/P308VQ <P)
M@R\N$X_Z)J^SF"T ,S@Z<&7XB6) M%08&1'+O\U)520<55_125<<AWH(GHAZ
MXSKF^,'( $I3/%IXHG6YL4U]T_4X?TN-?LTVD"F1RVKCJ#;QQ@YUS-&A]<1=
M76W]GRVSZ]>AK7DZT-80;<W37:*M\3O8M]+6W*N?^<7X:(:(V!TB8L^W)B)V
M>7+^Q^G9L7]4[/W;X.+D_)^GKT^"\Y-W=(&+OY]^N#50MC2:L]V<9E_V,&[7
M4=QNE,UV )$OK>_=AY"<<+IH)+\.JV(W8,E=7A5F8%,JLE<Y<X=)1C7U:-"_
M.($.=B&\\XSMWKK!T7/B3<![3[(DR6[(Q>GJ\,$^#?==<$-$WD#75HBJ3<G0
M&;!J$?)0B5YP/)G(1!):./3MGFYF^.<AT[D)[M<6*9,?MEZ;R'O2)@_4.'7]
MGZ9T(0Q]H1O C%I%T!2Q=)FF-1$="!S5=W2.42/90\>I7C$L3+4<["M^7MZ+
M^#DZ_'&0/ULF?XZV7?@<;:GP.?6L8N':',?>D4PX&8+Y%"+]D6/T=F4N+K,R
M9(+P#W"1D'HSO4&Q1'!&[Z(TE=#XZ1 3)H63,=$=NUKC79$:>]5/:OUT/U+K
M^?-!:@U2Z^M*K:>/6&IEJ09/+^MWL5I6C2A/NQ"A9['H'6442(A!3 UBZE&)
MJ6>#F%HAII0-I*51AX!9@@99_X=)K :YLQ%RQTWK7,+C_N\DJ8KI;2D=^O76
M5';PX2*X*)$]EA_G#EE_S"D_X30S[<B?@[ JL]KK.OW,;]R^GH=V+9]]T<S0
M1]62E5&1-FYMJB$U,&:/.-4J2]/1H/X:=7.2+2RA1E<;KWT53U%M4S5I'<=Y
MN'1($8HRN+(-<=0L"CK2@\-LAWI4].:@U?J!P^>YN,J(Q;?=^@&'H[H_("1H
M:0L(=@UC.2$49,F T#G,>K:L"?9(MYVFO *C)/D+(R>B7XNYXV!6F$RFH9ME
M1]'+-U6%:(:%HA8W4TVNL97#GYVM')8'T&AB=4]K];P:HZ8>;"P6F7H^ZI7+
M*^**;-75'1[T8"DL:AT!X'WJ'6!'<-@4U%_QC'_A9._6&' [$9W?UO#\:8_V
M-::-8M_<(,G-=*&#:BZ:V-/;C$H071PJ(UB\H3[" 8&X_]YM&4Y%N=C+$*2E
MB_L?U9J)CSBAZDM*4,N^.DJ54JBV(;N6J-RAO/4Z]EZWC%;WT[)<M49WJR/<
M.M@QR BLATF$:9F^A@7@-Z1[-A>LK="3J9Q+<N/EEL5=^JP/>9['&HK8 =#2
M=E #]08M[112J>G7@/3""I\K]CUDX<"&4,2*I!!$O5"KU5 X)^I. ;*X1Q>*
M*D42D [=W\1!J=HD.%Z)\:$*6^@Y:K5I;OE!Z__X&2.T)4:ZVJ73XT68P9.L
M*LUL]^^,30Y1G8PB))=)ZSA33B.YLP?XG@NN+5L23/<;1=<T#.01@ZK;;JC\
MBZV!RA__<7+V!OYW>>'9C/7L3># [ <JB<V@DABBU%\D2JV @[]EJ@(6U#,[
M?QAEA3_ I, YJL"JP%\P1ILA55A%]%,&K->N2F\Q9G5=F8I5R2W6\>F6[K>U
MH:HM"9H.3.F$GXFF2'A%KB82'B-Y@ I[*%\WO)E4B?ZR9@-<NOE_K&_^-9G\
M7 OW_N*,NG^KKA-7\1:V;F;(WRW)QB-.CAB>H" ;AW@2M>]N.\ZT)Q:M6GB5
M.004NV*[$2 8+E3*RX!]'$]8V*8Q2 2JS-]G6,8/<_]L+]H?F8MSU,ET4E9T
M#\C!A1U^R7Z<A?_)<N2A4\$CRS?61;Y9B*C";K2"C$+JR)8P4\-U!OOP2J1(
MEITLC)F;J/'!]73+Y8*,X%K7V/:65=N.3T:.S-)"!=I5>!\>S5 XN[-;;]3<
M&=Y721,,[@O:IDC?A@="5S(XYCKZ%&I-!=Z2<RMY5EU-U=E)C.7.;!%/B#^F
ML(<K,5;L^F/#&1*?^7C1F8K"8FIC2&R7-\E<-/\XCL62US /B*KIMNMG+T\"
M@D@!BT51BADFK&VB1;/.!0E6AL2C1M&(0Q?3129"3 '$E>.2HYLZ=LS7I$65
M*VZ%TQ2+;;&;47VF5C#RV+0.O<EGUY2E/WW*+_ VT;<=J:_K)2\Z^53<4Z/K
M.XCR6QT?RKEUNZ(OU 43.9-E>U+<^"*HI"F?/YQ7HKE'(@Z^D&5=[V)8<(]\
M,[W4JAD?%/A7+$!\-+F]=:K\GPU5_E3E_VS+J_QW?2]_69DPA#WN$/9XN35A
MCXO+X\N/GB&/]V^##^^.;P]U;"6UXU=0LH^:5ZCI(_\+/+]OOW'2O>2\9[E!
M+QBN1[*X$3[%K%NVP%#$[-3:GCWDCJ ',E*&N7%$-#T;^RYX):>IZ+??F/3$
MR*%W8]N8^@<A,1?[.TR5:<J.5*@AU!YE$('K($ON@.567*O$3-N!Y+L83^[;
M;\1GS+@7R<+Z+/1869HJ@UHU5G!ZSFH_ZW0)4*XSU*)M^O^RQQKAD^DT!K9W
M![O?-N-R>UK!:LV$*#L=;[?7C]/+R"P'=<@RR]7,^2O"4-/I:\/Z,NC1;&#K
M 0X#L<-+U B14_!!JQET+Z;DZ$V33L%@,@,,[.#EEB,#'[5@&])+7]_.^F%K
M[*S?3\Y.SH_?^1E:'\[?__/T KF7AK32T"?V,2"=MH.>Z<RS.]8;M+;DN$)K
M:!<P3JM[H(F0"Q *JB/#UVR:H]X%1AOV#MNM/Q426OZ(9FJ3&V'G&\P=4 8D
MU$S"/##DW39C<])(*A'EVP;G6@IJGQH[*XV7S44V&5 \@YGUR,3X=@!63PN4
M15'/=F [(<AKJ5&G,S &O%O=@E' Z3YG)K4)@I22DXU>"+[%OA0=$ S?P N9
M5G(WR"35I*Q3@P/EDQ83=&2OA"U6-KE/')'?."C&,PLE0@1(6]0>7T$$L!R$
M:D/H1?ST"*GF,59CVXS9,%+ICP5MHBI@8Y7!IS2[2?6-,.4]@6&VE-X!#,]=
M1Z5WO^[J7'S!U;F"H:2-6<:,-P$W\BR5$2T)=U9 Y G<%_Y+4;YY2?EG^'1M
M#?U&L=Z"WV4-/3LEIEG)R!)JM4===!C8@4UU5--(\XZJH.4W"Y@EPDV@^<;=
M#84SD7[#4+TN;,]QW>-"W6N_7?-KL/%H*,D.V/L=-XQJSV"0'-@J KL1<FT:
M!R3QTDZ#=;=G.J)8W/.O/N;=#;#9$=$U@FL0(8P"MUI.J*HT#>A/$3A2P@;W
MEBIUBQT#Z18+,U*QY/A:;26D?R@$'*.RT7ZI:?FC0/$%W'/C'[J5;?E!#3NN
MF2Z0Z%350:IM:K5JU"V$8N&S>2)-XRA/JUUQL:J:P"2\H:+#JTH!\'$:KC*X
M6XK+@;0\"OHBN<L$LQ^:"_!N=4L8_8LC<"\:E),+:FIN(402:7P3'#*490A
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MCBACJMRH?P7)U(XX-E@[Y+R PCY.I[95&I79[FGGZ2YV52:CSZ[Y1YER.>
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M/N:Z*W<\4X'N(7NX:+5 ID/TS(5>8M3+M8F$7[=9P,.4:./:681FK:L0?KC
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M0;P-,\3]F>.)BIZ#R8BJ.N0?6K>"?2MHB/X/;NF?KS&EY@TD8K5Z?]&^%1(
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M=_J2-%E6OA^YXL^&EK%O+]$"$4J @UHX?7DZ90H+Y"ORB+\@A1*\95K82[1
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MG5LF )MU* Q10%38G0%8Y&*DU$C(O8!QS>,5YD_3..KH*II"MVA 1NMLF*J
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M6+&681FX6^K2]:5T_0#&9T+I'PE[3*8$IRPA<WTMQ7:GJ%WO]HF9#MOUAV8
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M0_?^6RE <6B@FO%-*#"/BGB][)0$FB;OS='\B/UA_WZ"V?,/4$L! A0#%
M  @ QGO+7%MIE2L4&@  Y+@  !@              ( !     &5A,#(Y-#,T
M-RTX:U]T<FEL;&5R+FAT;5!+ 0(4 Q0    ( ,9[RUR?'\1F 6P  *P+!  5
M              "  4H:  !E83 R.30S-#<P,65X,3 M,2YH=&U02P$"% ,4
M    " #&>\M<8'!DDMX#   8#P  $0              @ %^A@  :6QL<BTR
M,#(V,#8Q,"YX<V102P$"% ,4    " #&>\M<I//6Q1,)  #V:   %0
M        @ &+B@  :6QL<BTR,#(V,#8Q,%]D968N>&UL4$L! A0#%     @
MQGO+7/[PP4XD#   #I$  !4              ( !T9,  &EL;'(M,C R-C V
M,3!?;&%B+GAM;%!+ 0(4 Q0    ( ,9[RUS/9[:Q7 @  )!C   5
M      "  2B@  !I;&QR+3(P,C8P-C$P7W!R92YX;6Q02P4&      8 !@"1
) 0  MZ@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>ea0294347-8k_triller_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ILLR="http://agba.com/20260610"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="illr-20260610.xsd" xlink:type="simple"/>
    <context id="AsOf2026-06-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769624</identifier>
        </entity>
        <period>
            <startDate>2026-06-10</startDate>
            <endDate>2026-06-10</endDate>
        </period>
    </context>
    <context id="From2026-06-102026-06-10_custom_CommonStock0.001ParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769624</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ILLR:CommonStock0.001ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-10</startDate>
            <endDate>2026-06-10</endDate>
        </period>
    </context>
    <context id="From2026-06-102026-06-10_custom_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769624</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ILLR:WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-10</startDate>
            <endDate>2026-06-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-06-10" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-06-10" id="Fact000004">0001769624</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-06-10" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-06-10" id="Fact000010">2026-06-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-06-10" id="Fact000011">TRILLER GROUP INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-06-10" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-06-10" id="Fact000013">001-38909</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-06-10" id="Fact000014">33-1473901</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-06-10" id="Fact000015">1301 N Broadway, STE 98065</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-06-10" id="Fact000016">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-06-10" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-06-10" id="Fact000018">90012</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-06-10" id="Fact000019">947</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-06-10" id="Fact000020">622-9043</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-06-10" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-06-10" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-06-10" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-06-10" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2026-06-102026-06-10_custom_CommonStock0.001ParValueMember"
      id="Fact000025">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-06-102026-06-10_custom_CommonStock0.001ParValueMember"
      id="Fact000026">ILLR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-06-102026-06-10_custom_CommonStock0.001ParValueMember"
      id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-06-102026-06-10_custom_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember"
      id="Fact000028">Warrants, each warrant exercisable for one-quarter of one share of Common Stock for $23.00 per full share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-06-102026-06-10_custom_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember"
      id="Fact000029">ILLRW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-06-102026-06-10_custom_WarrantsEachWarrantExercisableForOnequarterOfOneShareOfCommonStockFor23.00PerFullShareMember"
      id="Fact000030">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-06-10" id="Fact000031">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
